<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.1d3 20150301//EN" "http://jats.nlm.nih.gov/publishing/1.1d3/JATS-journalpublishing1.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.1d3" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="nlm-ta">PLoS Med</journal-id>
<journal-id journal-id-type="publisher-id">plos</journal-id>
<journal-id journal-id-type="pmc">plosmed</journal-id>
<journal-title-group>
<journal-title>PLOS Medicine</journal-title>
</journal-title-group>
<issn pub-type="ppub">1549-1277</issn>
<issn pub-type="epub">1549-1676</issn>
<publisher>
<publisher-name>Public Library of Science</publisher-name>
<publisher-loc>San Francisco, CA USA</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1371/journal.pmed.1002170</article-id>
<article-id pub-id-type="publisher-id">PMEDICINE-D-15-02850</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Research Article</subject>
</subj-group>
<subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Tropical diseases</subject><subj-group><subject>Neglected tropical diseases</subject><subj-group><subject>Viral hemorrhagic fevers</subject><subj-group><subject>Ebola hemorrhagic fever</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Infectious diseases</subject><subj-group><subject>Viral diseases</subject><subj-group><subject>Viral hemorrhagic fevers</subject><subj-group><subject>Ebola hemorrhagic fever</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Guinea</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Sierra Leone</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Health care</subject><subj-group><subject>Health care facilities</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>RNA viruses</subject><subj-group><subject>Filoviruses</subject><subj-group><subject>Ebola virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Microbiology</subject><subj-group><subject>Medical microbiology</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hemorrhagic fever viruses</subject><subj-group><subject>Ebola virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Pathology and laboratory medicine</subject><subj-group><subject>Pathogens</subject><subj-group><subject>Microbial pathogens</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hemorrhagic fever viruses</subject><subj-group><subject>Ebola virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Viral pathogens</subject><subj-group><subject>Hemorrhagic fever viruses</subject><subj-group><subject>Ebola virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Organisms</subject><subj-group><subject>Viruses</subject><subj-group><subject>Hemorrhagic fever viruses</subject><subj-group><subject>Ebola virus</subject></subj-group></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>People and places</subject><subj-group><subject>Geographical locations</subject><subj-group><subject>Africa</subject><subj-group><subject>Liberia</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social sciences</subject><subj-group><subject>Anthropology</subject><subj-group><subject>Cultural anthropology</subject><subj-group><subject>Religion</subject></subj-group></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Social sciences</subject><subj-group><subject>Sociology</subject><subj-group><subject>Religion</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Anatomy</subject><subj-group><subject>Body fluids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Biology and life sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject></subj-group></subj-group></subj-group><subj-group subj-group-type="Discipline-v3"><subject>Medicine and health sciences</subject><subj-group><subject>Physiology</subject><subj-group><subject>Body fluids</subject></subj-group></subj-group></subj-group></article-categories>
<title-group>
<article-title>Exposure Patterns Driving Ebola Transmission in West Africa: A Retrospective Observational Study</article-title>
<alt-title alt-title-type="running-head">Exposure Patterns Driving Ebola Transmission</alt-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" xlink:type="simple">
<collab>International Ebola Response Team</collab>
<xref ref-type="fn" rid="fn001"><sup>¶</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Agua-Agum</surname>
<given-names>Junerlyn</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0242-0186</contrib-id>
<name name-style="western">
<surname>Ariyarajah</surname>
<given-names>Archchun</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Aylward</surname>
<given-names>Bruce</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Bawo</surname>
<given-names>Luke</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-2656-8302</contrib-id>
<name name-style="western">
<surname>Bilivogui</surname>
<given-names>Pepe</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Blake</surname>
<given-names>Isobel M.</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Brennan</surname>
<given-names>Richard J.</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cawthorne</surname>
<given-names>Amy</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cleary</surname>
<given-names>Eilish</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Clement</surname>
<given-names>Peter</given-names>
</name>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Conteh</surname>
<given-names>Roland</given-names>
</name>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Cori</surname>
<given-names>Anne</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Dafae</surname>
<given-names>Foday</given-names>
</name>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Dahl</surname>
<given-names>Benjamin</given-names>
</name>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Dangou</surname>
<given-names>Jean-Marie</given-names>
</name>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Diallo</surname>
<given-names>Boubacar</given-names>
</name>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Donnelly</surname>
<given-names>Christl A.</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-9959-0706</contrib-id>
<name name-style="western">
<surname>Dorigatti</surname>
<given-names>Ilaria</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Dye</surname>
<given-names>Christopher</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Eckmanns</surname>
<given-names>Tim</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff010"><sup>10</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fallah</surname>
<given-names>Mosoka</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1154-8093</contrib-id>
<name name-style="western">
<surname>Ferguson</surname>
<given-names>Neil M.</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Fiebig</surname>
<given-names>Lena</given-names>
</name>
<xref ref-type="aff" rid="aff010"><sup>10</sup></xref>
</contrib>
<contrib contrib-type="author" corresp="yes" xlink:type="simple">
<name name-style="western">
<surname>Fraser</surname>
<given-names>Christophe</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff011"><sup>11</sup></xref>
<xref ref-type="corresp" rid="cor001">*</xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Garske</surname>
<given-names>Tini</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Gonzalez</surname>
<given-names>Lice</given-names>
</name>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hamblion</surname>
<given-names>Esther</given-names>
</name>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hamid</surname>
<given-names>Nuha</given-names>
</name>
<xref ref-type="aff" rid="aff006"><sup>6</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0003-4195-8517</contrib-id>
<name name-style="western">
<surname>Hersey</surname>
<given-names>Sara</given-names>
</name>
<xref ref-type="aff" rid="aff012"><sup>12</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Hinsley</surname>
<given-names>Wes</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jambei</surname>
<given-names>Amara</given-names>
</name>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Jombart</surname>
<given-names>Thibaut</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kargbo</surname>
<given-names>David</given-names>
</name>
<xref ref-type="aff" rid="aff007"><sup>7</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Keita</surname>
<given-names>Sakoba</given-names>
</name>
<xref ref-type="aff" rid="aff003"><sup>3</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kinzer</surname>
<given-names>Michael</given-names>
</name>
<xref ref-type="aff" rid="aff008"><sup>8</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>George</surname>
<given-names>Fred Kuti</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Godefroy</surname>
<given-names>Beatrice</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Gutierrez</surname>
<given-names>Giovanna</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Kannangarage</surname>
<given-names>Niluka</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mills</surname>
<given-names>Harriet L.</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
<xref ref-type="aff" rid="aff013"><sup>13</sup></xref>
<xref ref-type="aff" rid="aff014"><sup>14</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Moller</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff015"><sup>15</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Meijers</surname>
<given-names>Sascha</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Mohamed</surname>
<given-names>Yasmine</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8048-5663</contrib-id>
<name name-style="western">
<surname>Morgan</surname>
<given-names>Oliver</given-names>
</name>
<xref ref-type="aff" rid="aff012"><sup>12</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0001-5723-5028</contrib-id>
<name name-style="western">
<surname>Nedjati-Gilani</surname>
<given-names>Gemma</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Newton</surname>
<given-names>Emily</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Nouvellet</surname>
<given-names>Pierre</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Nyenswah</surname>
<given-names>Tolbert</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Perea</surname>
<given-names>William</given-names>
</name>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Perkins</surname>
<given-names>Devin</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Riley</surname>
<given-names>Steven</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-8618-7392</contrib-id>
<name name-style="western">
<surname>Rodier</surname>
<given-names>Guenael</given-names>
</name>
<xref ref-type="aff" rid="aff009"><sup>9</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Rondy</surname>
<given-names>Marc</given-names>
</name>
<xref ref-type="aff" rid="aff016"><sup>16</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Sagrado</surname>
<given-names>Maria</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Savulescu</surname>
<given-names>Camelia</given-names>
</name>
<xref ref-type="aff" rid="aff016"><sup>16</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Schafer</surname>
<given-names>Ilana J.</given-names>
</name>
<xref ref-type="aff" rid="aff012"><sup>12</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Schumacher</surname>
<given-names>Dirk</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff010"><sup>10</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Seyler</surname>
<given-names>Thomas</given-names>
</name>
<xref ref-type="aff" rid="aff016"><sup>16</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Shah</surname>
<given-names>Anita</given-names>
</name>
<xref ref-type="aff" rid="aff001"><sup>1</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Van Kerkhove</surname>
<given-names>Maria D.</given-names>
</name>
<xref ref-type="aff" rid="aff004"><sup>4</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Wesseh</surname>
<given-names>C. Samford</given-names>
</name>
<xref ref-type="aff" rid="aff002"><sup>2</sup></xref>
</contrib>
<contrib contrib-type="author" xlink:type="simple">
<name name-style="western">
<surname>Yoti</surname>
<given-names>Zabulon</given-names>
</name>
<xref ref-type="aff" rid="aff005"><sup>5</sup></xref>
</contrib>
</contrib-group>
<aff id="aff001"><label>1</label> <addr-line>World Health Organization, Geneva, Switzerland</addr-line></aff>
<aff id="aff002"><label>2</label> <addr-line>Ministry of Health, Monrovia, Liberia</addr-line></aff>
<aff id="aff003"><label>3</label> <addr-line>Ministry of Health, Conakry, Guinea</addr-line></aff>
<aff id="aff004"><label>4</label> <addr-line>MRC Centre for Outbreak Analysis and Modelling, Department of Infectious Disease Epidemiology, School of Public Health, Imperial College London, London, United Kingdom</addr-line></aff>
<aff id="aff005"><label>5</label> <addr-line>World Health Organization, Freetown, Sierra Leone</addr-line></aff>
<aff id="aff006"><label>6</label> <addr-line>World Health Organization, Monrovia, Liberia</addr-line></aff>
<aff id="aff007"><label>7</label> <addr-line>Ministry of Health, Freetown, Sierra Leone</addr-line></aff>
<aff id="aff008"><label>8</label> <addr-line>Centers for Disease Control and Prevention, Conakry, Guinea</addr-line></aff>
<aff id="aff009"><label>9</label> <addr-line>World Health Organization, Conakry, Guinea</addr-line></aff>
<aff id="aff010"><label>10</label> <addr-line>Department for Infectious Disease Epidemiology, Robert Koch Institute, Berlin, Germany</addr-line></aff>
<aff id="aff011"><label>11</label> <addr-line>Oxford Big Data Institute, Li Ka Shing Centre for Health Information and Discovery, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom</addr-line></aff>
<aff id="aff012"><label>12</label> <addr-line>Centers for Disease Control and Prevention, Freetown, Sierra Leone</addr-line></aff>
<aff id="aff013"><label>13</label> <addr-line>MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, United Kingdom</addr-line></aff>
<aff id="aff014"><label>14</label> <addr-line>School of Veterinary Sciences, University of Bristol, Bristol, United Kingdom</addr-line></aff>
<aff id="aff015"><label>15</label> <addr-line>European Centre for Disease Prevention and Control, Conakry, Guinea</addr-line></aff>
<aff id="aff016"><label>16</label> <addr-line>Epiconcept, Conakry, Guinea</addr-line></aff>
<contrib-group>
<contrib contrib-type="editor" xlink:type="simple">
<name name-style="western">
<surname>von Seidlein</surname>
<given-names>Lorenz</given-names>
</name>
<role>Academic Editor</role>
<xref ref-type="aff" rid="edit1"/>
</contrib>
</contrib-group>
<aff id="edit1"><addr-line>Mahidol-Oxford Tropical Medicine Research Unit, THAILAND</addr-line></aff>
<author-notes>
<fn fn-type="conflict" id="coi001">
<p>The authors have declared that no competing interests exist.</p>
</fn>
<fn fn-type="con">
<p><list list-type="simple">
<list-item><p><bold>Conceptualization:</bold> IMB ACo CAD NMF CF HLM.</p></list-item>
<list-item><p><bold>Data curation:</bold> JA-A AA BA LB PB IMB RJB ACa ECPC RC ACo MC FD BDa J-MD BDi CAD ID CD TE MF NMF LF CF TG LG EH NH SH WH AJ TJ DK SK MK FKG BG GG NK HLM TM GN-G SM YM OM EN PN TN WP DP SR GR MR MS CS IJS DS TS AS MDVK CSW ZY.</p></list-item>
<list-item><p><bold>Formal analysis:</bold> IMB ACo CF NMF HLM.</p></list-item>
<list-item><p><bold>Funding acquisition:</bold> CAD NMF CF SR.</p></list-item>
<list-item><p><bold>Methodology:</bold> IMB ACo CAD NMF CF HLM.</p></list-item>
<list-item><p><bold>Supervision:</bold> CD CAD NMF CF.</p></list-item>
<list-item><p><bold>Visualization:</bold> IMB ACo CF HLM.</p></list-item>
<list-item><p><bold>Writing – original draft:</bold> BA IMB ACo CD CAD NMF LF CF HLM.</p></list-item>
<list-item><p><bold>Writing – review &amp; editing:</bold> JA-A AA BA LB PB IMB RJB ACa ECPC RC ACo MC FD BDa J-MD BDi CAD ID CD TE MF NMF LF CF TG LG EH NH SH WH AJ TJ DK SK MK FKG BG GG NK HLM TM GN-G SM YM OM EN PN TN WP DP SR GR MR MS CS IJS DS TS AS MDVK CSW ZY.</p></list-item></list></p>
</fn>
<fn fn-type="other" id="fn001">
<p>¶ The International Ebola Response Team comprises the authors listed in this article in alphabetical order</p>
</fn>
<corresp id="cor001">* E-mail: <email xlink:type="simple">dyec@who.int</email> (CD); <email xlink:type="simple">neil.ferguson@imperial.ac.uk</email> (NMF); <email xlink:type="simple">christophe.fraser@well.ox.ac.uk</email> (CF)</corresp>
</author-notes>
<pub-date pub-type="epub">
<day>15</day>
<month>11</month>
<year>2016</year>
</pub-date>
<pub-date pub-type="collection">
<month>11</month>
<year>2016</year>
</pub-date>
<volume>13</volume>
<issue>11</issue>
<elocation-id>e1002170</elocation-id>
<history>
<date date-type="received">
<day>24</day>
<month>9</month>
<year>2015</year>
</date>
<date date-type="accepted">
<day>7</day>
<month>10</month>
<year>2016</year>
</date>
</history>
<permissions>
<license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">
<license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/" xlink:type="simple">Creative Commons CC0</ext-link> public domain dedication.</license-p>
</license>
</permissions>
<self-uri content-type="pdf" xlink:href="info:doi/10.1371/journal.pmed.1002170"/>
<abstract>
<sec id="sec001">
<title>Background</title>
<p>The ongoing West African Ebola epidemic began in December 2013 in Guinea, probably from a single zoonotic introduction. As a result of ineffective initial control efforts, an Ebola outbreak of unprecedented scale emerged. As of 4 May 2015, it had resulted in more than 19,000 probable and confirmed Ebola cases, mainly in Guinea (3,529), Liberia (5,343), and Sierra Leone (10,746). Here, we present analyses of data collected during the outbreak identifying drivers of transmission and highlighting areas where control could be improved.</p>
</sec>
<sec id="sec002">
<title>Methods and Findings</title>
<p>Over 19,000 confirmed and probable Ebola cases were reported in West Africa by 4 May 2015. Individuals with confirmed or probable Ebola (“cases”) were asked if they had exposure to other potential Ebola cases (“potential source contacts”) in a funeral or non-funeral context prior to becoming ill. We performed retrospective analyses of a case line-list, collated from national databases of case investigation forms that have been reported to WHO. These analyses were initially performed to assist WHO’s response during the epidemic, and have been updated for publication.</p>
<p>We analysed data from 3,529 cases in Guinea, 5,343 in Liberia, and 10,746 in Sierra Leone; exposures were reported by 33% of cases. The proportion of cases reporting a funeral exposure decreased over time. We found a positive correlation (<italic>r</italic> = 0.35, <italic>p &lt;</italic> 0.001) between this proportion in a given district for a given month and the within-district transmission intensity, quantified by the estimated reproduction number (<italic>R</italic>). We also found a negative correlation (<italic>r</italic> = −0.37, <italic>p &lt;</italic> 0.001) between <italic>R</italic> and the district proportion of hospitalised cases admitted within ≤4 days of symptom onset. These two proportions were not correlated, suggesting that reduced funeral attendance and faster hospitalisation independently influenced local transmission intensity. We were able to identify 14% of potential source contacts as cases in the case line-list. Linking cases to the contacts who potentially infected them provided information on the transmission network. This revealed a high degree of heterogeneity in inferred transmissions, with only 20% of cases accounting for at least 73% of new infections, a phenomenon often called super-spreading. Multivariable regression models allowed us to identify predictors of being named as a potential source contact. These were similar for funeral and non-funeral contacts: severe symptoms, death, non-hospitalisation, older age, and travelling prior to symptom onset. Non-funeral exposures were strongly peaked around the death of the contact. There was evidence that hospitalisation reduced but did not eliminate onward exposures. We found that Ebola treatment units were better than other health care facilities at preventing exposure from hospitalised and deceased individuals. The principal limitation of our analysis is limited data quality, with cases not being entered into the database, cases not reporting exposures, or data being entered incorrectly (especially dates, and possible misclassifications).</p>
</sec>
<sec id="sec003">
<title>Conclusions</title>
<p>Achieving elimination of Ebola is challenging, partly because of super-spreading. Safe funeral practices and fast hospitalisation contributed to the containment of this Ebola epidemic. Continued real-time data capture, reporting, and analysis are vital to track transmission patterns, inform resource deployment, and thus hasten and maintain elimination of the virus from the human population.</p>
</sec>
</abstract>
<abstract abstract-type="toc">
<p>In this retrospective observational study, Christophe Fraser and colleagues analyze the exposure patterns associated with Ebola transmission during the 2013-2016 epidemic in West Africa.</p>
</abstract>
<abstract abstract-type="summary">
<title>Author Summary</title>
<sec id="sec004">
<title>Why Was This Study Done?</title>
<list list-type="bullet">
<list-item><p>Knowing how and from whom individuals acquire infection can help inform the response to limit the impact of an epidemic; this study presents updated versions of analyses initially performed to assist the international response during the 2013–2016 Ebola epidemic in West Africa.</p></list-item>
<list-item><p>Over 19,000 individuals with confirmed or probable Ebola (“cases”) were reported in West Africa by 4 May 2015.</p></list-item>
<list-item><p>Cases were asked whether they had exposure to potential Ebola cases (“potential source contacts”) in a funeral or non-funeral context prior to becoming ill.</p></list-item>
</list>
</sec>
<sec id="sec005">
<title>What Did the Researchers Do and Find?</title>
<list list-type="bullet">
<list-item><p>We analysed data from 3,529 cases in Guinea, 5,343 in Liberia, and 10,746 in Sierra Leone; exposures were reported by 33% of cases.</p></list-item>
<list-item><p>Non-funeral exposures were strongly peaked around the time of death of the contact.</p></list-item>
<list-item><p>There was evidence of super-spreading, with only 20% of cases accounting for at least 73% of new infections.</p></list-item>
</list>
</sec>
<sec id="sec006">
<title>What Do These Findings Mean?</title>
<list list-type="bullet">
<list-item><p>Safe funeral practices and fast hospitalisation contributed to the containment of this Ebola epidemic.</p></list-item>
<list-item><p>The data are highly detailed despite the challenging circumstances in the three countries; however, the analyses were limited by data quality, mostly missing data and incorrect entries.</p></list-item>
<list-item><p>In light of viral persistence in reservoirs, it is vital to maintain active surveillance and analysis of Ebola outbreaks to avoid and contain future outbreaks.</p></list-item>
</list>
</sec>
</abstract>
<funding-group>
<award-group id="award001">
<funding-source>
<institution>EU</institution>
</funding-source>
<award-id>278433-PREDEMICS</award-id>
<principal-award-recipient>
<name name-style="western">
<surname>Donnelly</surname>
<given-names>Christl</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award002">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000265</institution-id>
<institution>Medical Research Council</institution>
</institution-wrap>
</funding-source>
<award-id>MR/K010174/1</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1154-8093</contrib-id>
<name name-style="western">
<surname>Ferguson</surname>
<given-names>Neil M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award003">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000865</institution-id>
<institution>Bill and Melinda Gates Foundation</institution>
</institution-wrap>
</funding-source>
<award-id>OPP1092240</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1154-8093</contrib-id>
<name name-style="western">
<surname>Ferguson</surname>
<given-names>Neil M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award004">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000057</institution-id>
<institution>National Institute of General Medical Sciences</institution>
</institution-wrap>
</funding-source>
<award-id>1U01GM110721-01</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1154-8093</contrib-id>
<name name-style="western">
<surname>Ferguson</surname>
<given-names>Neil M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<award-group id="award005">
<funding-source>
<institution-wrap>
<institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/501100000272</institution-id>
<institution>National Institute for Health Research</institution>
</institution-wrap>
</funding-source>
<award-id>HPRU-2012-10080</award-id>
<principal-award-recipient>
<contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-1154-8093</contrib-id>
<name name-style="western">
<surname>Ferguson</surname>
<given-names>Neil M.</given-names>
</name>
</principal-award-recipient>
</award-group>
<funding-statement>We acknowledge the Medical Research Council for Award Number MR/K010174/1 (Principal Investigator NMF), the Bill and Melinda Gates Foundation for Award Number OPP1092240 (NMF), the National Institute of General Medical Sciences for Award Number 1U01GM110721-01 (Principal Investigator NMF), the EU for Award Number 278433-PREDEMICS (to CAD), and the National Institute for Health Research for Award Number HPRU-2012-10080 (Principal Investigator NMF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.</funding-statement>
</funding-group>
<counts>
<fig-count count="4"/>
<table-count count="1"/>
<page-count count="23"/>
</counts>
<custom-meta-group>
<custom-meta id="data-availability">
<meta-name>Data Availability</meta-name>
<meta-value>Data are available from the WHO for researchers who meet the criteria for access to confidential data. Requests for access to these data should be addressed to Peter Graaff, Director of the Ebola response at WHO (<email xlink:type="simple">graaffp@who.int</email>).</meta-value>
</custom-meta>
</custom-meta-group>
</article-meta>
</front>
<body>
<sec id="sec007" sec-type="intro">
<title>Introduction</title>
<p>The ongoing West African Ebola epidemic began in December 2013 in Guinea, probably from a single zoonotic introduction [<xref ref-type="bibr" rid="pmed.1002170.ref001">1</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref002">2</xref>]. As a result of ineffective initial control efforts, an Ebola outbreak of unprecedented scale emerged. As of 4 May 2015, it had resulted in more than 19,000 probable and confirmed Ebola cases, mainly in Guinea (3,529), Liberia (5,343), and Sierra Leone (10,746) (see section 1.3 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for WHO case definitions). Control measures for Ebola are well known and based on past experience [<xref ref-type="bibr" rid="pmed.1002170.ref003">3</xref>–<xref ref-type="bibr" rid="pmed.1002170.ref006">6</xref>]. However, the lack of local experience in handling Ebola outbreaks coupled with severely limited health care resources and poor coordination in the international response led to an initial failure to prevent exponential spread of the outbreak [<xref ref-type="bibr" rid="pmed.1002170.ref007">7</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref008">8</xref>]. International partners, including the World Health Organization (WHO), emphasised four interventions [<xref ref-type="bibr" rid="pmed.1002170.ref009">9</xref>]: (1) prompt identification and isolation of cases, (2) tracing of contacts, (3) safe and dignified burials, and (4) community awareness and social mobilisation. Following several months of intensive efforts to enhance control measures and local community mobilisation, incidence dramatically fell in all three countries [<xref ref-type="bibr" rid="pmed.1002170.ref010">10</xref>] (<xref ref-type="fig" rid="pmed.1002170.g001">Fig 1</xref>, top row).</p>
<fig id="pmed.1002170.g001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pmed.1002170.g001</object-id>
<label>Fig 1</label>
<caption>
<title>Total number of confirmed and probable cases by week, and percentage who reported funeral and non-funeral exposures.</title>
<p>Total number of confirmed and probable cases by week is shown in the top row. Percentage of cases who reported a non-funeral exposure (triangles) or a funeral exposure (circles) is shown in the second row. The shaded regions represent the 95% confidence intervals around the proportions. Note that cases can report more than one exposure, and so percentages need not add to 100%. exp., exposure.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.g001" xlink:type="simple"/>
</fig>
<p>To quantify the risk factors for transmission, we analysed reported exposure data collected during the epidemic in Guinea, Liberia, and Sierra Leone. We hypothesized that many reported exposures corresponded to transmission events, and that we could therefore discover correlates of transmission and properties of the transmission network by studying available exposure records. Analyses were informed by epidemiological knowledge accrued during previous Ebola outbreaks and by previous expertise in outbreak analysis. The descriptive analyses and association studies were not prespecified, but rather analyses were designed in response to preliminary examination of the accruing data, and in discussion amongst partners in the team. We also hypothesized that if the interventions deployed to interrupt transmission were effective in this epidemic, we should observe an association between the rate of epidemic spread at the district level and the proportion of cases reporting funeral attendance and/or slow hospitalisation. This latter analysis was decided upon before statistical implementation, and was thus hypothesis-driven. We did not have data to assess the effect of contact tracing or community mobilisation.</p>
<p>Data were collated during the outbreak to assist with surveillance and the response. National case databases were shared with WHO and were merged to form a joint line-list (one line of data for each case). The retrospective analyses presented here use data from the three main affected countries (Guinea, Liberia, and Sierra Leone) and were first conducted in real time in September and October 2014 as part of the response to the public health emergency. They were shared with WHO, national authorities, and international agencies working in the three countries and contributed to the planning and monitoring of the control effort.</p>
<p>In summary, the objectives of these analyses are to understand the drivers of local transmission, the timing of transmission events relative to clinical timelines, and the characteristics of the transmission network. These are different from and complement the objectives of our previous papers [<xref ref-type="bibr" rid="pmed.1002170.ref011">11</xref>–<xref ref-type="bibr" rid="pmed.1002170.ref014">14</xref>]. However, aspects of the process are the same as in those previous analyses: data cleaning, time series of incidence, and method of estimation for the reproduction number. The same exposure data were used to estimate the incubation period and serial interval in previous analyses [<xref ref-type="bibr" rid="pmed.1002170.ref011">11</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref012">12</xref>]. The dataset analysed is the most comprehensive available on the current epidemic, and represents a unique resource with which to increase our understanding of the outbreak and of Ebola transmission in general. The analysis and presentation of the characteristics of exposures, transmission network, transmission risks, characteristics of potential transmitters and multiple transmitters, health care worker (HCW) exposures, and correlations between epidemic growth and behaviour are all novel.</p>
</sec>
<sec id="sec008" sec-type="materials|methods">
<title>Methods</title>
<sec id="sec009">
<title>Ethical Considerations</title>
<p>This paper is based on data collected during surveillance and response activities for Ebola in Guinea, Liberia, and Sierra Leone. The work is based on routine national surveillance for Ebola, for which informed consent is not needed. The surveillance was carried out under WHO Integrated Disease Surveillance and Response guidelines in Africa (the recommended disease notification system). Data were reported to WHO under the obligations of the International Health Regulations. All work was carried out under this legal framework. All information on individual patients has been anonymized for analysis and presentation.</p>
</sec>
<sec id="sec010">
<title>Data</title>
<p>Information from Ebola cases was collected using a standardised case investigation form [<xref ref-type="bibr" rid="pmed.1002170.ref012">12</xref>] and the Epi Info Viral Hemorrhagic Fever Application (<ext-link ext-link-type="uri" xlink:href="https://epiinfovhf.codeplex.com/" xlink:type="simple">https://epiinfovhf.codeplex.com/</ext-link>). The cleaning of the data has been described previously [<xref ref-type="bibr" rid="pmed.1002170.ref011">11</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref012">12</xref>].</p>
<p>The case investigation form records information on exposures that may have led to the infection of the case. Cases were asked if in the month prior to symptom onset they had had contact with a potential Ebola case and/or had attended a funeral. Cases could report details of up to five exposure events with potential source contacts (up to three exposures with potential source contacts outside of a funeral context, and up to two exposures at funerals of potential source contacts); from Autumn 2014, an abbreviated form was introduced with up to two non-funeral and one funeral exposure (see <xref ref-type="supplementary-material" rid="pmed.1002170.s003">S2</xref>–<xref ref-type="supplementary-material" rid="pmed.1002170.s007">S6</xref> Texts). Cases reported the name of the person they were exposed to and provided details about their relationship to that person (e.g., family, friend, neighbour) and the nature of the exposure (e.g., touched bodily fluids or shared belongings). All names were anonymized using the SHA-1 hashing algorithm [<xref ref-type="bibr" rid="pmed.1002170.ref015">15</xref>]. Here, we use “potential source contact”, “source contact”, or “contact” to describe the person who was named as a potential Ebola source, and “exposure” to describe the potential transmission event that took place between the case and the potential source contact (see <xref ref-type="boxed-text" rid="pmed.1002170.box001">Box 1</xref> for terminology). The potential source contact may be alive or dead at the time of the exposure.</p>
<boxed-text id="pmed.1002170.box001" position="float">
<sec id="sec011">
<title>Box 1. Terminology: Cases, Contacts, and Exposures</title>
<list list-type="bullet">
<list-item><p>Case: An individual in the line-list with confirmed or probable (CP) Ebola virus disease status using WHO case definitions [<xref ref-type="bibr" rid="pmed.1002170.ref016">16</xref>] (see section 1.3 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). None of our results changed substantially when analyses were run on confirmed, probable, and suspected cases combined (see section 3 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p></list-item>
<list-item><p>Exposure: An event reported by a case in which the case came into contact with an ill or dead person or attended their funeral. Cases could report more than one exposure.</p></list-item>
<list-item><p>Non-funeral exposure: Exposure with an ill person, who may be alive or dead, but not at a funeral. Cases could report up to three non-funeral exposures.</p></list-item>
<list-item><p>Funeral exposure: Attendance at a funeral, which could involve touching the corpse. Cases could report up to two funeral exposures.</p></list-item>
<list-item><p>Potential source contact, source contact, or contact: The person with whom the exposure was made.</p></list-item>
<list-item><p>Matched contact: A potential source contact whom we could identify as a reported case in the line-list.</p></list-item>
<list-item><p>Matched exposure: An exposure between a case and his or her matched potential source contact.</p></list-item>
</list>
</sec>
</boxed-text>
<p>Ebola cases are classified as confirmed, probable, or suspected. Here we analysed data from all CP cases unless otherwise stated. In practice, different countries implemented slightly different case definitions; hence, we also performed sensitivity analyses considering confirmed, probable, and suspected cases combined (see section 3 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
</sec>
<sec id="sec012">
<title>Analysis of Predictors of Naming an Exposure</title>
<p>We assessed whether cases who reported at least one non-funeral or funeral exposure were different from cases who did not report that type of exposure. This allowed us to assess whether cases who report exposures are representative of the line-list. Multivariable logistic regressions were performed using predictors identified as significant (<italic>p &lt;</italic> 0.05) in univariable logistic regressions (see section 1.11 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for a list of predictors included in univariable analyses). The most parsimonious yet adequate multivariable model was then identified (using the Akaike information criterion) through backwards stepwise model selection (see final results in Tables b and c in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
</sec>
<sec id="sec013">
<title>Matching Named Potential Source Contacts to the Case Line-List</title>
<p>To identify potential transmission pairs and thus elucidate transmission networks, we examined whether named potential source contacts were themselves Ebola cases. We searched for all named contacts among the names of cases in the line-list to find possible matches. Multiple checks were undertaken to verify the consistency of all matched case-contact pairs according to a set of rules (see section 1.4 and Figure a in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>), in particular comparing dates of symptom onset and exposure.</p>
<p>Importantly, the exposure data analysed here are retrospective and are completely distinct from prospective contact tracing data, where cases are asked who they had contact with <italic>after</italic> they became ill; we do not analyse prospective contact tracing data here, as such data were not available to us, but rather focus on identified potential source contacts.</p>
</sec>
<sec id="sec014">
<title>Assessing Changes in Infection Control in Health Care Facilities over Time</title>
<p>We hypothesized that the observed decrease in the proportion of HCWs (the positions reported include medical staff and other health-care-facility-based workers) among cases over time (see Figure f in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>) was due to decreased unprotected exposure to patients. To address this issue, we compared the estimated slopes from two linear regression models of (1) the proportion of HCWs among cases over time and (2) the proportion of hospitalised patients over time (see section 1.5 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). Note that we define “hospitalisation” as admission to a number of different health care facilities (see <xref ref-type="boxed-text" rid="pmed.1002170.box002">Box 2</xref>).</p>
<boxed-text id="pmed.1002170.box002" position="float">
<sec id="sec015">
<title>Box 2. Hospitalisation</title>
<p>We use “hospitalisation” to mean the admission of any patient to a health care facility, as recorded in the case investigation form. This refers to a variety of events in a range of facilities, including</p>
<list list-type="bullet">
<list-item><p>Ebola treatment centres or units</p></list-item>
<list-item><p>Ebola holding centres or units</p></list-item>
<list-item><p>Community care centres</p></list-item>
<list-item><p>Hospitals</p></list-item>
<list-item><p>Health centres, health units, or post-maternal or child health posts (clinics)</p></list-item>
<list-item><p>Referral centres</p></list-item>
</list>
<p>If a case is hospitalised for Ebola, WHO guidelines recommend that the case be isolated. The list above includes a variety of health care facilities where isolation capacity and quality will vary. It should be noted that the meaning of “date of hospitalisation” may be different among cases, depending on how many and which type of facilities they reported visiting in the course of their disease. However, the data do not allow us to distinguish between different meanings of hospitalisation. It should also be noted that not all transfers of patients between different types of health care units may have been recorded in the case investigation form. Data cleaning for hospital type is described in section 1.4 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>.</p>
</sec>
</boxed-text>
</sec>
<sec id="sec016">
<title>Fitting Distributions to Intervals from Clinical Event to Exposure</title>
<p>Understanding when onward exposure occurred in the clinical course of infection in a primary case could inform the focus of interventions, for instance for early detection of cases or for improving the safety of funerals. We analysed the timing of non-funeral exposure events relative to the following clinical events of the named contacts: onset of symptoms, hospitalisation, and death. Here, we describe the analysis of the time from symptom onset to onward exposure; the analyses for hospitalisation and death were similar. We fitted (by maximum likelihood) a distribution to the observed delays between symptom onset and exposure. In brief (see section 1.8 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for more detail), this likelihood accounted for (1) multiple exposures (when multiple exposures were reported, only one was likely to have led to infection, so exposures were weighted accordingly), (2) inaccurate recall of contacts, (3) inaccurate recall of dates of exposures, (4) errors in data entry. In order to address issues 2 to 4, we fitted a mixture of two offset lognormal distributions: the more peaked we regarded as the signal, and the broader we regarded as the noise (see section 1.8 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). We then interpreted the signal distribution as our best estimate of actual infection times. Missing delays were imputed by random draws from the observed data.</p>
<p>The analyses described above showed that the non-funeral exposure events were concentrated shortly after the onset of symptoms and around the day of death (see <xref ref-type="sec" rid="sec020">Results</xref>). We performed an additional analysis to further explore whether one of these two clinical events was more influential for the timing of onward non-funeral exposure events. We compared the ability to predict (1) the date of death of the source contact based on date of symptom onset of the source contact and the date of exposure reported by the case and (2) the date of symptom onset of the source contact based on date of death of the source contact and date of onward exposure (see Figure o and section 1.9 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). These two models assume that the timing of onward exposure is mainly determined by the date of symptom onset (model 1) or by the date of death (model 2).</p>
</sec>
<sec id="sec017">
<title>Analysis of the Network of Reported Exposures</title>
<p>The transmission network can be described by a network of nodes (cases) linked by directed edges (exposures leading to transmission). In order to characterise the heterogeneities in transmission, we analysed the properties of this network. We looked at separate networks for funeral and non-funeral exposures (see section 1.10 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). For each, we analysed the out-degree distribution, i.e., the distribution of the number of cases naming the same matched contact, which can be seen as a proxy for the distribution of the number of secondary cases per index case. Several parametric distributions were fitted to each of the two observed out-degree distributions using maximum likelihood estimation (see section 1.10 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for a list of the distributions explored). The Akaike information criterion corrected for finite sample sizes (AICc) [<xref ref-type="bibr" rid="pmed.1002170.ref017">17</xref>] was then used to select the best distribution. For the best-fitting distribution, 95% confidence intervals for the distribution parameters were obtained using the likelihood ratio test, and the confidence interval for the corresponding distribution was obtained by numerical sampling.</p>
<p>We derived the variance and the coefficient of variation for the offspring distribution (the distribution of the number of secondary cases infected by each case), based on the assumption that the network of exposures shown in Figure p in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> is a sample of the full transmission network (see section 1.10 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
</sec>
<sec id="sec018">
<title>Analysis of Predictors of Being Named and Being Named Multiple Times as a Potential Source Contact</title>
<p>To obtain further insight into potential drivers of transmission, we analysed the data to see if there were predictors of being a potential source contact. We performed four analyses: (1) a logistic regression, which identified predictors of being named as a non-funeral contact, one or more times; (2) a logistic regression restricted to cases who died, which identified predictors of being named as a funeral contact, one or more times; (3) a negative binomial regression, which identified predictors of being named multiple times as a non-funeral contact, conditional on being named at least once; and (4) a negative binomial regression restricted to cases who died, which identified predictors of being named multiple times as a funeral contact, conditional on being named at least once. Predictors included in the univariable regressions were as defined in section 1.11 of <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>, and the method for identifying the final parsimonious multivariable model is described above. We performed these analyses on confirmed, probable, and suspected contacts who had been named by CP cases. This allowed us to understand the role of suspected contacts in onward transmission compared to CP contacts.</p>
</sec>
<sec id="sec019">
<title>Correlates of Transmission Intensity</title>
<p>We explored the relationship between district-level (second administrative division) transmission intensity and (1) the proportion of cases reporting funeral attendance amongst those reporting any exposure and (2) the proportion of cases ever hospitalised and the proportion of cases hospitalised ≤4 days (4 days was the median delay from symptom onset to hospitalisation; see Figure m in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for sensitivity analysis to that threshold). The transmission intensity was quantified by the reproduction number, <italic>R</italic>, which estimates the average number of secondary cases per index case [<xref ref-type="bibr" rid="pmed.1002170.ref011">11</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref018">18</xref>] (see section 1.6 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). We estimated the reproduction number (<inline-formula id="pmed.1002170.e001"><alternatives><graphic id="pmed.1002170.e001g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.1002170.e001" xlink:type="simple"/><mml:math display="inline" id="M1"><mml:msubsup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>) and the proportion (<inline-formula id="pmed.1002170.e002"><alternatives><graphic id="pmed.1002170.e002g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.1002170.e002" xlink:type="simple"/><mml:math display="inline" id="M2"><mml:msubsup><mml:mrow><mml:mi>p</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>), for every district (<italic>d</italic>) in all three countries over monthly intervals (<italic>m</italic>). (<inline-formula id="pmed.1002170.e003"><alternatives><graphic id="pmed.1002170.e003g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.1002170.e003" xlink:type="simple"/><mml:math display="inline" id="M3"><mml:msubsup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula> was estimated with the R package “EpiEstim” [<xref ref-type="bibr" rid="pmed.1002170.ref019">19</xref>] using district-level incidence, presented in <xref ref-type="fig" rid="pmed.1002170.g001">Fig 1</xref> at the country level; see section 1.6 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>.) The relationship between (<inline-formula id="pmed.1002170.e004"><alternatives><graphic id="pmed.1002170.e004g" mimetype="image" position="anchor" xlink:href="info:doi/10.1371/journal.pmed.1002170.e004" xlink:type="simple"/><mml:math display="inline" id="M4"><mml:msubsup><mml:mrow><mml:mi>R</mml:mi></mml:mrow><mml:mrow><mml:mi>m</mml:mi></mml:mrow><mml:mrow><mml:mi>d</mml:mi></mml:mrow></mml:msubsup></mml:math></alternatives></inline-formula>) and the proportions was explored using linear regressions. As these quantities were estimated from a sample of data with a level of uncertainty, we used a custom linear regression method that accounts for measurement error [<xref ref-type="bibr" rid="pmed.1002170.ref020">20</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref021">21</xref>]. The method to compute the correlation coefficient was also adapted to account for measurement error (see section 1.7 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
<p>All data cleaning and analyses were performed using <italic>R</italic> software [<xref ref-type="bibr" rid="pmed.1002170.ref022">22</xref>].</p>
</sec>
</sec>
<sec id="sec020" sec-type="results">
<title>Results</title>
<sec id="sec021">
<title>Characteristics of Exposures</title>
<p>Of the 19,618 CP Ebola cases in the line-list, 6,403 (33%) cases reported one or more exposures (<xref ref-type="table" rid="pmed.1002170.t001">Table 1</xref>), giving a total of 9,711 reported exposures. Temporal trends in case incidence and reported exposures by country are shown in <xref ref-type="fig" rid="pmed.1002170.g001">Fig 1</xref>. The proportion of cases reporting exposures varied by country (<xref ref-type="table" rid="pmed.1002170.t001">Table 1</xref>); in general, we found that exposure data were less complete for Guinea. Cases reporting exposures were broadly representative of all cases in the line-list (see Tables b and c and Figure c in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for a comparison of characteristics between cases who reported exposures and those who did not).</p>
<table-wrap id="pmed.1002170.t001" position="float">
<object-id pub-id-type="doi">10.1371/journal.pmed.1002170.t001</object-id>
<label>Table 1</label> <caption><title>Number of confirmed or probable (CP) cases, exposures, and matched CP-CP contacts and details of the type of exposure and the reported relationship between the case and potential source contact.</title></caption>
<alternatives>
<graphic id="pmed.1002170.t001g" mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.t001" xlink:type="simple"/>
<table>
<colgroup>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
<col align="left" valign="middle"/>
</colgroup>
<thead>
<tr>
<th align="left">Detail</th>
<th align="left">All</th>
<th align="left">Guinea</th>
<th align="left">Liberia</th>
<th align="left">Sierra Leone</th>
</tr>
</thead>
<tbody>
<tr>
<td align="left"><bold><italic>Numbers of cases</italic>, <italic>exposures</italic>, <italic>and matched contacts</italic></bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left"><bold>Total cases</bold></td>
<td align="left">19,618</td>
<td align="left">3,529</td>
<td align="left">5,343</td>
<td align="left">10,746</td>
</tr>
<tr>
<td align="left"><bold>Cases reporting an exposure</bold></td>
<td align="left">6,403 (32.6%)</td>
<td align="left">892 (25.3%)</td>
<td align="left">2,078 (38.9%)</td>
<td align="left">3,433 (31.9%)</td>
</tr>
<tr>
<td align="left">Only non-funeral</td>
<td align="left">4,183 (65.3%)</td>
<td align="left">571 (64.0%)</td>
<td align="left">1,717 (82.6%)</td>
<td align="left">1,895 (55.2%)</td>
</tr>
<tr>
<td align="left">Only funeral</td>
<td align="left">247 (3.9%)</td>
<td align="left">40 (4.5%)</td>
<td align="left">49 (2.4%)</td>
<td align="left">158 (4.6%)</td>
</tr>
<tr>
<td align="left">Both</td>
<td align="left">1,973 (30.8%)</td>
<td align="left">281 (31.5%)</td>
<td align="left">312 (15.0%)</td>
<td align="left">1,380 (40.2%)</td>
</tr>
<tr>
<td align="left"><bold>Total reported exposures</bold></td>
<td align="left">9,711</td>
<td align="left">1,366</td>
<td align="left">2,803</td>
<td align="left">5,542</td>
</tr>
<tr>
<td align="left">Funeral</td>
<td align="left">2,382 (24.5%)</td>
<td align="left">325 (23.8%)</td>
<td align="left">396 (14.1%)</td>
<td align="left">1,661 (30.0%)</td>
</tr>
<tr>
<td align="left">Non-funeral</td>
<td align="left">7,329 (75.5%)</td>
<td align="left">1,041 (76.2%)</td>
<td align="left">2,407 (85.9%)</td>
<td align="left">3,881 (70.0%)</td>
</tr>
<tr>
<td align="left"><bold>Total matched exposures</bold></td>
<td align="left">1,352 (13.9%)</td>
<td align="left">319 (23.4%)</td>
<td align="left">345 (12.3%)</td>
<td align="left">688 (12.4%)</td>
</tr>
<tr>
<td align="left">Funeral</td>
<td align="left">243 (18.0%)</td>
<td align="left">68 (21.3%)</td>
<td align="left">24 (7.0%)</td>
<td align="left">151 (21.9%)</td>
</tr>
<tr>
<td align="left">Non-funeral</td>
<td align="left">1,109 (82.0%)</td>
<td align="left">251 (78.7%)</td>
<td align="left">321 (93.0%)</td>
<td align="left">537 (78.1%)</td>
</tr>
<tr>
<td align="left"><bold>Total number of matched potential source contacts (cases who were named as contacts multiple times are only counted once)</bold></td>
<td align="left">753</td>
<td align="left">163</td>
<td align="left">237</td>
<td align="left">353</td>
</tr>
<tr>
<td align="left"><bold><italic>Details about types of exposures</italic></bold></td>
<td align="left"/>
<td align="left"/>
<td align="left"/>
<td align="left"/>
</tr>
<tr>
<td align="left"><bold>Funeral, with type of exposure reported</bold></td>
<td align="left">1,657 (69.6%)</td>
<td align="left">216 (66.5%)</td>
<td align="left">273 (68.9%)</td>
<td align="left">1,168 (70.3%)</td>
</tr>
<tr>
<td align="left">Touched corpse</td>
<td align="left">1,071 (64.6%)</td>
<td align="left">154 (71.3%)</td>
<td align="left">167 (61.2%)</td>
<td align="left">750 (64.2%)</td>
</tr>
<tr>
<td align="left">Did not touch corpse</td>
<td align="left">586 (35.4%)</td>
<td align="left">62 (28.7%)</td>
<td align="left">106 (38.8%)</td>
<td align="left">418 (35.8%)</td>
</tr>
<tr>
<td align="left"><bold>Non-funeral, with type of exposure reported</bold></td>
<td align="left">2,461 (33.6%)</td>
<td align="left">102 (9.8%)</td>
<td align="left">1,430 (59.4%)</td>
<td align="left">929 (23.9%)</td>
</tr>
<tr>
<td align="left">Belongings</td>
<td align="left">1,379 (56.0%)</td>
<td align="left">30 (29.4%)</td>
<td align="left">757 (52.9%)</td>
<td align="left">592 (63.7%)</td>
</tr>
<tr>
<td align="left">Bodily fluids</td>
<td align="left">1,318 (53.6%)</td>
<td align="left">35 (34.3%)</td>
<td align="left">711 (49.7%)</td>
<td align="left">572 (61.6%)</td>
</tr>
<tr>
<td align="left">Within same household</td>
<td align="left">937 (38.1%)</td>
<td align="left">31 (30.4%)</td>
<td align="left">492 (34.4%)</td>
<td align="left">414 (44.6%)</td>
</tr>
<tr>
<td align="left">Direct physical</td>
<td align="left">2,136 (86.8%)</td>
<td align="left">72 (70.6%)</td>
<td align="left">1,262 (88.3%)</td>
<td align="left">802 (86.3%)</td>
</tr>
<tr>
<td align="left"><bold>Funeral, with the relationship reported</bold></td>
<td align="left">1,952 (81.9%)</td>
<td align="left">53 (16.3%)</td>
<td align="left">360 (90.9%)</td>
<td align="left">1,539 (92.7%)</td>
</tr>
<tr>
<td align="left">Close family</td>
<td align="left">1,079 (55.3%)</td>
<td align="left">34 (64.2%)</td>
<td align="left">194 (53.9%)</td>
<td align="left">851 (55.3%)</td>
</tr>
<tr>
<td align="left">Extended family</td>
<td align="left">550 (28.2%)</td>
<td align="left">11 (20.8%)</td>
<td align="left">96 (26.7%)</td>
<td align="left">443 (28.8%)</td>
</tr>
<tr>
<td align="left">Friend</td>
<td align="left">121 (6.2%)</td>
<td align="left">1 (1.9%)</td>
<td align="left">50 (13.9%)</td>
<td align="left">70 (4.5%)</td>
</tr>
<tr>
<td align="left">Neighbour</td>
<td align="left">154 (7.9%)</td>
<td align="left">1 (1.9%)</td>
<td align="left">9 (2.5%)</td>
<td align="left">144 (9.4%)</td>
</tr>
<tr>
<td align="left">Health care</td>
<td align="left">6 (0.3%)</td>
<td align="left">0 (0%)</td>
<td align="left">0 (0%)</td>
<td align="left">6 (0.4%)</td>
</tr>
<tr>
<td align="left">Other</td>
<td align="left">42 (2.2%)</td>
<td align="left">6 (11.3%)</td>
<td align="left">11 (3.1%)</td>
<td align="left">25 (1.6%)</td>
</tr>
<tr>
<td align="left"><bold>Non-funeral, with the relationship reported</bold></td>
<td align="left">6,105 (83.3%)</td>
<td align="left">242 (23.2%)</td>
<td align="left">2,249 (93.4%)</td>
<td align="left">3,614 (93.1%)</td>
</tr>
<tr>
<td align="left">Close family</td>
<td align="left">3,610 (59.1%)</td>
<td align="left">148 (61.2%)</td>
<td align="left">1,336 (59.4%)</td>
<td align="left">2,126 (58.8%)</td>
</tr>
<tr>
<td align="left">Extended family</td>
<td align="left">1,435 (23.5%)</td>
<td align="left">48 (19.8%)</td>
<td align="left">483 (21.5%)</td>
<td align="left">904 (25.0%)</td>
</tr>
<tr>
<td align="left">Friend</td>
<td align="left">335 (5.5%)</td>
<td align="left">10 (4.1%)</td>
<td align="left">182 (8.1%)</td>
<td align="left">143 (4.0%)</td>
</tr>
<tr>
<td align="left">Neighbour</td>
<td align="left">431 (7.1%)</td>
<td align="left">12 (5.0%)</td>
<td align="left">113 (5.0%)</td>
<td align="left">306 (8.5%)</td>
</tr>
<tr>
<td align="left">Health care</td>
<td align="left">103 (1.7%)</td>
<td align="left">6 (2.5%)</td>
<td align="left">43 (1.9%)</td>
<td align="left">54 (1.5%)</td>
</tr>
<tr>
<td align="left">Other</td>
<td align="left">191 (3.1%)</td>
<td align="left">18 (7.4%)</td>
<td align="left">92 (4.1%)</td>
<td align="left">81 (2.2%)</td>
</tr>
</tbody>
</table>
</alternatives>
<table-wrap-foot>
<fn id="t001fn001"><p>Not all cases who reported funeral exposure explicitly reported whether they had touched the corpse. Cases who reported non-funeral exposure could report multiple types of exposure: belongings—“touched or shared the linens, clothes, or dishes/eating utensils of the case [contact]”; bodily fluids—“touched the body fluids of the case (blood, vomit, saliva, urine, feces)”; in same household—“slept, ate, or spent time in the same household or room as the case”; direct physical—“had direct physical contact with the body of the case”. Relationship was not reported for every exposure. We grouped reported relationships into classes: “close family” is defined as siblings, marital, and parent-child relationships; other family members are considered “extended family”; “neighbour” is defined as tenants, lodgers, landlords, and neighbours; “health care” is defined as HCW-patient relationships and caregivers, or any reference to a patient; “other” includes traditional healers, contacts through religious practice, and transport contacts. Type of exposure and relationship type are illustrated graphically in Figure d in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>.</p></fn>
</table-wrap-foot>
</table-wrap>
<p>Exposure at funerals is a known risk factor for Ebola infection [<xref ref-type="bibr" rid="pmed.1002170.ref023">23</xref>–<xref ref-type="bibr" rid="pmed.1002170.ref025">25</xref>], and 25% of cases who reported any exposure in the current outbreak reported exposures at funerals. Most cases (89%) reporting a funeral exposure also reported one or more non-funeral exposures.</p>
<p>Cases were asked to provide details on the nature of their exposures and their relationships with the contacts, which are shown in <xref ref-type="table" rid="pmed.1002170.t001">Table 1</xref>. Overall, 87% of exposures occurred between family members (of those where the relationship was reported). Up until the introduction of the new case investigation form (see <xref ref-type="supplementary-material" rid="pmed.1002170.s003">S2</xref>–<xref ref-type="supplementary-material" rid="pmed.1002170.s007">S6</xref> Texts), non-funeral exposures were recorded as one or more types (e.g., an exposure could simultaneously involve shared belongings and exposure to bodily fluids). Of those non-funeral exposures for which the type of exposure was reported, over 90% were reported to involve contact with bodily fluids and/or direct physical contact, and 38% were reported as occurring in a household (defined as having slept, eaten, or spent time in the same household or room as the contact). These patterns did not change significantly over time (see Figure e in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). For funeral exposures, cases were asked whether they had touched the corpse. Of those giving a response, 65% reported having touched the corpse, with this proportion being greatest for Guinea (71%) and least for Liberia (61%). This proportion declined significantly after October 2014 (<italic>p &lt;</italic> 0.001; see Figure h in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>), most notably in Sierra Leone.</p>
</sec>
<sec id="sec022">
<title>Matching Named Potential Source Contacts to the Case Line-List</title>
<p>We were able to identify 14% of potential source contacts as cases in the line-list. Our ability to match contacts did not vary substantially over time (see Figure i in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>) or geographically (see Figure c in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
</sec>
<sec id="sec023">
<title>Characteristics of the Transmission Network</title>
<p>The analysis of matched exposures provides information on the transmission network underpinning the Ebola epidemic (<xref ref-type="fig" rid="pmed.1002170.g002">Fig 2</xref>). There was evidence of modest assortativity in exposure patterns by sex (see Table i in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>) and country-specific patterns by age (see Table j in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). The most important statistic characterising the transmission network is the out-degree distribution, the number of times each person was named as a contact by other Ebola cases. The observed out-degree distribution was best fitted by a logarithmic probability distribution for both funeral and non-funeral contacts (<xref ref-type="fig" rid="pmed.1002170.g002">Fig 2A</xref>; see sections 1.10 and 2.8 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). Since the network is not known in its entirety, but only through a sample of cases and their matched contacts, additional assumptions were needed to infer the true offspring distribution (the distribution of the number of secondary cases infected by each case) from the observed out-degree distribution. Under the assumption that the matched exposures are representative of the underlying transmission network, we find high to extreme variability in the offspring distribution (<xref ref-type="fig" rid="pmed.1002170.g002">Fig 2B</xref>; see section 1.10 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). The estimated coefficient of variation for the offspring distribution ranges from 1.6 to 5.6 depending on assumptions (see section 1.10 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). This implies that 5% of cases accounted for at least 30% of all new infections and that 20% of cases accounted for at least 73% of new infections (<xref ref-type="fig" rid="pmed.1002170.g002">Fig 2B</xref>; see Figure q in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>), a phenomenon termed super-spreading [<xref ref-type="bibr" rid="pmed.1002170.ref026">26</xref>]. Super-spreading was found to affect both non-funeral and funeral transmissions equally (see Tables f and g in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
<fig id="pmed.1002170.g002" position="float">
<object-id pub-id-type="doi">10.1371/journal.pmed.1002170.g002</object-id>
<label>Fig 2</label>
<caption>
<title>Contact network.</title>
<p>(A) The out-degree distribution of the network of exposures shows the probability that a named contact is named as an exposure by a certain number of cases. The squares represent the observed data. The black line shows the maximum likelihood logarithmic distribution, with 95% confidence interval in grey. (B) The cumulative density function of the derived offspring distribution. The two black lines (edges) show two scenarios (see Figure q in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for details). (C) A sample of the network of all cases (see Figure p in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for full network) and the contacts they have named as having been exposed to. Individuals (cases and contacts) are shown as nodes, and exposures as directed arrows from contacts to cases. Arrows are red for funeral exposures, black for non-funeral exposures, and blue for multiple exposures involving both non-funeral and funeral exposures. Square nodes are males, round nodes females, and triangles unknown. Red nodes are cases who have died, blue nodes are cases who have survived, and grey nodes are cases with no recorded outcome.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.g002" xlink:type="simple"/>
</fig>
</sec>
<sec id="sec024">
<title>Transmission Risk Relative to Onset of Symptoms and Death</title>
<p>One key potential determinant of the risk of onward transmission is the stage of progression of clinical illness. The risk of transmission was found to increase over time since symptom onset (<xref ref-type="fig" rid="pmed.1002170.g003">Fig 3A</xref>), peaking 2 days after onset, with some exposures estimated to have occurred more than 2 weeks after onset. Our model estimates a small probability of transmission before symptom onset; however, we do not regard this as strong evidence for pre-symptomatic transmission: all reported dates are prone to recall bias, but it is likely that the date of symptom onset is more uncertain than dates of hospitalisation and death, as it is subjective, so individuals may interpret symptom onset differently.</p>
<fig id="pmed.1002170.g003" position="float">
<object-id pub-id-type="doi">10.1371/journal.pmed.1002170.g003</object-id>
<label>Fig 3</label>
<caption>
<title>Observed and fitted distribution of reported time to non-funeral exposure from symptom onset, hospitalisation, and death of the contact.</title>
<p>Time from symptom onset (A), death (B), and hospitalisation (C) of the contact to time of exposure. The green curves show the overall best fits, and the red curves show the best fits for the “signal” distribution (all obtained by maximum likelihood). The red-shaded areas indicate the 95% confidence intervals of the fitted “signal” distribution. The histogram shows a random set of exposure midpoints (in some instances, only a start or an end date of exposure is recorded; in those instances, the missing date is numerically imputed). Note that the fitting procedure is not performed on the midpoints but fully incorporates the exposure window (see section 1.8 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). The inset panels are the observed cumulative distribution functions for the midpoint (black line) and start and end (grey lines) of the exposures.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.g003" xlink:type="simple"/>
</fig>
<p>Transmission events from non-funeral exposures were estimated to be strongly peaked on the day of and the day after the death of the contact (<xref ref-type="fig" rid="pmed.1002170.g003">Fig 3B</xref>). In all, 44% of non-funeral exposures to potential source contacts who died were estimated to occur on or after the date of death of the contact. Furthermore, individuals who died were more likely to be named as non-funeral contacts (univariable odds ratio [OR] = 2.10 [95% CI: 1.68, 2.66]).</p>
<p>We sought to determine whether date of death or date of symptom onset was the stronger predictor of transmission risk. We found that date of death was the stronger predictor, indicating that the timing of death is the strongest determinant of when transmission occurs (see Figure o in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
</sec>
<sec id="sec025">
<title>Exposures Occurring in Hospitals and after Hospitalisation</title>
<p>Hospitalisation (see <xref ref-type="boxed-text" rid="pmed.1002170.box002">Box 2</xref> for definition of hospitalisation, which in this context is isolation from the community by admission to any health care facility) aims to improve the clinical outcomes of patients with Ebola virus disease, and also to reduce onward exposures. We found that hospitalised cases (who were hospitalised at any stage of their infection) had a reduced risk of being named as a non-funeral source contact (univariable OR = 0.78 [95% CI: 0.66, 0.92]) and as a funeral source contact (OR = 0.43 [95% CI: 0.29, 0.63]) compared to cases never hospitalised. This indicates that hospitalisation reduced but did not eliminate onward exposures. The impact of hospitalisation on limiting onward exposure was stronger in Guinea than in Liberia (significantly so for non-funeral exposures, see Tables m and n in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). The protective effect of hospitalisation on exposure in Sierra Leone was not statistically significant. There was no significant increase in the effect of hospitalisation over time for any of the three countries (see Tables m and n in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). Previously, we examined the timing of transmission risk relative to symptom onset and death. Using the same method to characterise the timing of exposure events relative to hospitalisation, we found that a substantial proportion (42% [95% CI: 12%, 54%]) of non-funeral exposures from hospitalised source contacts occurred after their hospitalisation (<xref ref-type="fig" rid="pmed.1002170.g003">Fig 3C</xref>).</p>
<p>Our definition of hospitalisation covers a broad range of health care facility types (<xref ref-type="boxed-text" rid="pmed.1002170.box002">Box 2</xref>), each with varying levels of infection control [<xref ref-type="bibr" rid="pmed.1002170.ref027">27</xref>]. In particular, as part of the international response to the epidemic, an unprecedented number of Ebola treatment units (ETUs) were built to care for patients. The previous analysis considered all types of hospitalisation together. When we disaggregated hospitalisation by ETU versus other facilities, we found that ETUs were better than other health care facilities at preventing exposure from hospitalised cases and at providing safer management of corpses. In ETUs, the observed proportion of non-funeral exposures from hospitalised cases occurring after hospitalisation was significantly lower than in non-ETU facilities (<italic>p &lt;</italic> 0.001, see Figure n in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). Moreover, hospitalisation in an ETU reduced the risk of being named as a funeral contact compared with non-hospitalised cases (univariable OR = 0.30 [95% CI: 0.16, 0.50]) more than hospitalisation in a non-ETU facility did (OR = 0.72 [95% CI: 0.39, 1.23]; also see multivariable analyses in Table l in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> and the next section). Although for non-funeral contacts univariable ORs were not significant, a multivariable analysis indicated similar effects (see Table k in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>).</p>
<p>Overall, our analyses demonstrate that hospitalisation reduced infectious exposures to cases, but that the effectiveness of hospital isolation measures varied by country and facility type, with substantial scope for improvements.</p>
</sec>
<sec id="sec026">
<title>Epidemiological Characteristics of Potential Transmitters</title>
<p>To further explore the characteristics of individuals who were named as potential source contacts (and therefore potential transmitters), we also performed systematic multivariable logistic regressions on the risk of being named as a potential source contact (see Tables k and l in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). Based on the final multivariable model, individuals significantly more likely to be named as a non-funeral contact were those who were more severely affected at presentation (with fever [versus no fever], OR = 1.52 [95% CI: 1.20, 1.95]; with bleeding [versus no bleeding], OR = 1.40 [95% CI: 1.07, 1.81]; unconscious [versus conscious], OR = 1.98 [95% CI: 1.26, 3.03]); those who died (versus survivors, OR = 2.04 [95% CI: 1.50, 2.79]; confirmed cases (versus suspected cases, OR = 2.45 [95% CI: 2.01, 2.99]); and probable cases (versus suspected cases, OR = 1.91, [95% CI: 1.51, 2.41]). In addition, cases who were never hospitalised (versus cases hospitalised in an ETU) were more likely to be named as a non-funeral contact (OR = 1.61 [95% CI: 1.30, 2.00]). Finally, adults (≥16 versus &lt;16 years old, OR = 1.87 [95% CI: 1.52, 2.34]) and those who reported travelling outside of their village before they became ill (versus not travelling, OR = 1.73 [95% CI: 1.35, 2.18]) were also more likely to be named as a non-funeral potential source contact.</p>
<p>Similar predictors were found for individuals being named as funeral contacts: more severely affected cases (fever versus no fever, OR = 1.81 [95% CI: 1.08, 3.18]; respiratory versus no respiratory symptoms, OR = 1.65 [95% CI: 1.09, 2.54]), adults (≥16 versus &lt;16 years old, OR = 2.44 [95% CI: 1.47, 4.36]), cases not hospitalised (versus hospitalised in an ETU, OR = 5.56 [95% CI: 2.94, 11.11]), those who reported travelling before they became ill (versus not travelling, OR = 2.47 [95% CI: 1.50, 3.90]), confirmed cases (versus suspected cases, OR = 1.98 [95% CI: 1.28, 3.11]), probable cases (versus suspected cases, OR = 2.03 [95% CI: 1.21, 3.42]), and those who were reported as Ebola cases after death (versus before death, OR = 1.64 [95% CI: 1.12, 2.40]).</p>
</sec>
<sec id="sec027">
<title>Epidemiological Factors Associated with Being a Multiple Transmitter</title>
<p>To determine whether there were any factors associated with being multiply identified as a potential source contact, we conducted a multivariable negative binomial regression to explore predictors of the number of times cases were named as non-funeral and funeral source contacts, conditional on being named at least once (see Tables p and q in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). Cases with reported haemorrhagic symptoms were found to be named as non-funeral contacts 1.67 times more often than cases not reporting these symptoms (95% CI: 1.07, 2.64). Cases hospitalised in an ETU were found to be named as non-funeral contacts 0.50 as many times as non-hospitalised cases (95% CI: 0.33, 0.73). Also, HCWs were found to be named as non-funeral contacts 0.48 as many times as non-HCWs (95% CI: 0.23, 0.96). Travel outside one’s village of residence prior to becoming ill was the only significant predictor for a case to be named multiple times as a funeral contact (relative number of times being named compared to cases who did not report travelling was on average 4.41 [95% CI: 2.01, 10.55]).</p>
</sec>
<sec id="sec028">
<title>No Difference in Exposure Risk between the Sexes</title>
<p>Sex did not appear as an important predictor of exposure risk in any of the analyses that we performed.</p>
</sec>
<sec id="sec029">
<title>Exposures Involving Health Care Workers</title>
<p>HCWs have been at particularly high risk of infection, especially during the early part of the epidemic [<xref ref-type="bibr" rid="pmed.1002170.ref028">28</xref>]. HCWs reported that 49% of their non-funeral exposures were with other HCWs or patients, versus 0.6% reported by non-HCWs. Consequently, HCWs reported a lower percentage of exposures with family members (44%) compared to non-HCWs (91%; see Figure f in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). This demonstrates that HCWs were often infected whilst working. Consistent with these data, the matched contacts reported by HCWs were more likely to have evidence of hospitalisation at some point in their illness than the matched contacts of non-HCWs (OR = 2.91 [95% CI: 1.57, 5.81]).</p>
<p>In the absence of data on the total number of HCWs working in each of the three countries over time, we could not estimate the relative risk of infection of HCWs compared to non-HCWs. However, several indicators point to falling risk through time. Since June 2014, the proportion of HCWs among all cases has decreased over time (see Figure f in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). The rate of decrease in this proportion (estimated monthly relative decrease since June: 21% [95% CI: 18%, 24%]) was faster than that seen in the incidence of hospitalised cases (estimated monthly relative decrease: 12% [95% CI: 10%, 14%]; see also Figures f and g in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>), suggesting an improvement in infection control measures and increased awareness of Ebola among HCWs over time.</p>
</sec>
<sec id="sec030">
<title>Population Correlates of Epidemic Intensity</title>
<p>The analyses presented so far describe individual risks of infection. We next explored, in a hypothesis-driven manner, whether local epidemic transmission intensity was correlated with local population measures of presumed heightened risk of infection.</p>
<p>We first examined whether the proportion of cases reporting funeral exposures in each district by month was correlated with the estimated reproduction number <italic>R</italic> in that district at that time. Having accounted for uncertainty in the estimates of both quantities [<xref ref-type="bibr" rid="pmed.1002170.ref020">20</xref>] (see section 1.7 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>), we found a positive correlation for Liberia (<italic>r</italic><sup>2</sup> <italic>=</italic> 0.30, <italic>p =</italic> 0.013) and Sierra Leone (<italic>r</italic><sup>2</sup> <italic>=</italic> 0.23, <italic>p &lt;</italic> 0.001) and no significant correlation for Guinea (<italic>r</italic><sup>2</sup> <italic>=</italic> 0.001, <italic>p =</italic> 0.667) (<xref ref-type="fig" rid="pmed.1002170.g004">Fig 4</xref>; see Figure j and Table d in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). This analysis suggests that across the three countries an absolute reduction of 10% in the proportion reporting funeral exposures would lead to an absolute reduction of 0.10 in <italic>R</italic> (95% CI: 0.05, 0.15; <italic>p &lt;</italic> 0.001). In particular, reducing the proportion reporting funeral exposures to less than 29% (95% CI: 21%, 38%) would be sufficient to reduce <italic>R</italic> below 1, the threshold value for achieving control of the epidemic. However, this result varies by country, and is an association that does not prove causation, since reductions in funeral exposures could have been accompanied by changes in other control measures and other effects of community mobilisation. In that case, the measure is a surrogate for the total effect of interventions that correlate with reduced funeral exposures.</p>
<fig id="pmed.1002170.g004" position="float">
<object-id pub-id-type="doi">10.1371/journal.pmed.1002170.g004</object-id>
<label>Fig 4</label>
<caption>
<title>Correlation between local transmission intensity and local population measures of presumed heightened risk of infection.</title>
<p>Correlation between local transmission intensity and proportion of cases reporting funeral exposures among those reporting any exposure (left) and proportion of cases hospitalised within ≤4 days of symptom onset among those hospitalised (right). The scatter plots show these monthly proportions against monthly estimated reproduction numbers <italic>R</italic> (method as previous [<xref ref-type="bibr" rid="pmed.1002170.ref011">11</xref>]) for the supplemented incidence (i.e., incidence based on two data sources including the line-list, see [<xref ref-type="bibr" rid="pmed.1002170.ref012">12</xref>]). Each point is a district-month. Trend lines are shown with 95% confidence intervals (shaded areas). We use a weighted regression method that takes account of the uncertainties in the data [<xref ref-type="bibr" rid="pmed.1002170.ref020">20</xref>]. The area of each circle is proportional to the weight of that point (see section 1.7 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). In the bottom row, the black trend line is for the whole dataset. See Figures j and l and Table d in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref> for details, including trend line parameters. exp., exposure.</p>
</caption>
<graphic mimetype="image" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.g004" xlink:type="simple"/>
</fig>
<p>Another factor potentially influencing changes in transmission intensity is how promptly cases are hospitalised and isolated. We found no association between the proportion of cases that were hospitalised and the estimated district-level reproduction number <italic>R</italic> (see Figure k in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>), likely because the line-list predominantly includes cases who have been hospitalised. However, we found a negative association between the estimated district-level <italic>R</italic> and the proportion of hospitalised cases admitted within ≤4 days after onset of symptoms in Liberia (<italic>r</italic><sup>2</sup> = 0.22, <italic>p =</italic> 0.039) and Sierra Leone (<italic>r</italic><sup>2</sup> = 0.32, <italic>p &lt;</italic> 0.001). No significant correlation was found in Guinea (<italic>r</italic><sup>2</sup> = 0.02, <italic>p =</italic> 0.377) (<xref ref-type="fig" rid="pmed.1002170.g004">Fig 4</xref>; see Figures l and m in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). This analysis quantifies the impact that earlier hospitalisation has in reducing transmission. Across all three countries we estimate that increasing the proportion of cases hospitalised within ≤4 days of symptom onset by 10% would reduce <italic>R</italic> by 0.19 (95% CI: 0.12, 0.25; <italic>p &lt;</italic> 0.001). In particular, if 64% (95% CI: 59%, 68%) of hospitalised cases are admitted within ≤4 days, <italic>R</italic> is predicted to be &lt;1. Again, the effect varied by country.</p>
<p>We found no correlation between the two predictors we analysed, i.e., the proportion of cases reporting funeral exposure and the proportion of cases hospitalised within ≤4 d of symptom onset (naïve <italic>r</italic><sup>2</sup> <italic>=</italic> 0.001, <italic>p =</italic> 0.711; see section 2.5 in <xref ref-type="supplementary-material" rid="pmed.1002170.s002">S1 Text</xref>). This shows that both factors are independently associated with the level of transmission, at least in Liberia and Sierra Leone, and, together, they explain a substantial proportion (approximately 55%) of the variance in epidemic transmission intensity observed in these two countries.</p>
</sec>
</sec>
<sec id="sec031" sec-type="conclusions">
<title>Discussion</title>
<p>The analyses in this paper draw on 9,711 exposures to potential sources of infection, to provide a quantitative basis for understanding Ebola epidemiology and to validate the choice of interventions used to combat Ebola in the current and future outbreaks. These analyses were initially performed in September/October 2014 as part of the WHO Ebola response during the epidemic and have been updated to be shared with the scientific community.</p>
<p>The current Ebola outbreak has been of unprecedented scale, occurring across three countries of diverse cultures with varying levels of urbanisation. Our analysis provides a unique overview of Ebola transmission that complements detailed investigations that have been performed in localised settings in this and previous outbreaks [<xref ref-type="bibr" rid="pmed.1002170.ref029">29</xref>–<xref ref-type="bibr" rid="pmed.1002170.ref033">33</xref>]. Small studies may allow more detailed reconstruction of transmission and identification of risk factors for infection by comparing cases and non-cases, which is not feasible at a larger scale. However, analyses such as identifying district-level correlates for transmission intensity and determining when exposures occur with respect to clinical events are only possible with this unique large-scale dataset.</p>
<p>Our analysis confirms that exposure to Ebola cases at funerals is an important amplifier of Ebola transmission, in line with a study focused in Sierra Leone [<xref ref-type="bibr" rid="pmed.1002170.ref032">32</xref>]. The significant correlation we found between the district-level reported frequency of funeral exposures and local transmission intensity provides support for the policy emphasis on safe and dignified burials. This effect was not replicated in Guinea, which suggests we have less understanding of drivers of transmission in that country.</p>
<p>Our results also highlight the importance of exposure to individuals who are dead or dying from Ebola outside the funeral context, as has been observed in past outbreaks [<xref ref-type="bibr" rid="pmed.1002170.ref004">4</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref023">23</xref>–<xref ref-type="bibr" rid="pmed.1002170.ref025">25</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref034">34</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref035">35</xref>]. Cases who died were more likely to be named as contacts than those who survived, with most transmission occurring within a few days on either side of the reported date of death—coincident with the timing of peak viral load [<xref ref-type="bibr" rid="pmed.1002170.ref034">34</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref036">36</xref>]. This reinforces existing evidence [<xref ref-type="bibr" rid="pmed.1002170.ref004">4</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref023">23</xref>–<xref ref-type="bibr" rid="pmed.1002170.ref025">25</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref034">34</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref035">35</xref>] that exposures to individuals who are dead or dying from Ebola contribute to transmission, even where those exposures occur outside the specific context of funerals. As in past outbreaks [<xref ref-type="bibr" rid="pmed.1002170.ref003">3</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref004">4</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref023">23</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref025">25</xref>], and consistent with other analyses of the current outbreak [<xref ref-type="bibr" rid="pmed.1002170.ref029">29</xref>], such exposures have most often been between close family members, perhaps explaining why most such contacts have occurred in the household.</p>
<p>Early hospitalisation in facilities with the ability to isolate patients effectively—a key element of control efforts for Ebola—is clearly a priority to reduce community transmission. Investigations of the initial phase of this epidemic, as well as previous outbreaks, have highlighted the potential role of within-hospital transmission before or shortly after Ebola is identified as the causative agent [<xref ref-type="bibr" rid="pmed.1002170.ref037">37</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref038">38</xref>]. Here we found that hospitalisation, defined broadly as anything from visiting a clinic to admission to an ETU, reduced transmission risk, showing that prompt hospitalisation may be an effective intervention as long as appropriate control measures are applied. However, hospitalisation did not eliminate transmission risk, indicating that improvements in infection control are needed in many health care settings. It should be noted that the meaning of date of hospitalisation may be different among cases, depending on how many and which types of facilities they visited in the course of their disease, and furthermore that there is potential for misclassification in the recording or interpretation of information on hospitalisation. In particular, while the health care facility of first admission was commonly reported, patient transfers to other facilities may not have always been recorded. Thus, there may be ambiguity about the type of health care facility a case was in at a particular time. Such missing information reduces our ability to resolve differences between types of facilities in their effectiveness at implementing case isolation, which could lead to underestimation of differences between facility types in isolation effectiveness. However, our results are broadly consistent with analyses of the outbreak in Conakry [<xref ref-type="bibr" rid="pmed.1002170.ref029">29</xref>]. Half of reported non-funeral exposures where the matched contact was eventually hospitalised occurred after the reported date of hospitalisation. These results underscore the importance of further improving infection control in all health care facilities, but particularly in non-ETUs. However, in contexts where hospital bed capacity is insufficient or infection control in health care settings is imperfect, greater consideration might be given to measures to reduce within-family exposure—for example, via education and/or providing a home protection kit with hand disinfectant, protective equipment, and clear guidance for those caring for sick family members.</p>
<p>Another striking feature of the epidemic revealed by our analysis is the high level of heterogeneity in the number of times a case is named as a potential source contact. Such heterogeneity has been observed for some other emerging infectious disease epidemics [<xref ref-type="bibr" rid="pmed.1002170.ref026">26</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref039">39</xref>–<xref ref-type="bibr" rid="pmed.1002170.ref041">41</xref>], in particular the Middle East respiratory syndrome coronavirus outbreaks [<xref ref-type="bibr" rid="pmed.1002170.ref042">42</xref>]. In principle, understanding the drivers of this heterogeneity might allow for the design of targeted interventions. However, our analysis found very few epidemiological predictors for being named as a source contact multiple times, suggesting that simple demographic characteristics are unlikely to pinpoint those most at risk of super-spreading. Heterogeneity in transmission, particularly when associated with transmission in close communities, implies that epidemic trajectories may be difficult to predict at a local level [<xref ref-type="bibr" rid="pmed.1002170.ref043">43</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref044">44</xref>]. Local flare-ups are possible when case numbers are low and declining. Continued vigilance during the ongoing declining phase of the epidemic is essential.</p>
<p>The data we have analysed have several limitations. Not all Ebola cases are recorded in the national databases shared with WHO. Moreover, data on exposures were reported by only approximately one-third of cases. The remainder of cases may not have had the chance to report exposures or may have been unable to recall any. Additionally, data collection teams and methods varied by country, district, and hospital facility, meaning observational or collection bias may have affected the data. All data (e.g., symptoms at presentation) were either self-reported or reported by friends/family or inferred by the interviewer and may therefore suffer from subjectivity and recall bias. In particular, there may be biases in the exposures reported—for example, cases may recall funerals or exposures to family in more detail or have different perceptions of what constitutes exposure. Recall and data entry errors (e.g., spelling mistakes, mistyped dates, and misclassification) and missing data may have affected our results, for example, they limited our ability to match the contacts named in the reported exposures. We accounted for this in our analyses as much as possible by discarding inconsistent data, imputing missing data, or explicitly accounting for noise. However, some biases may remain. Performing these quantitative analyses on such a large scale was only possible due to the enormous commitment of Ebola responders in the region throughout the epidemic, which is particularly remarkable given the very challenging circumstances in the affected countries.</p>
<p>In generalising our findings, we need to recognise the relatively unique nature of this crisis. Measures that were promoted, including emphasising bed capacity, safe funerals, behaviour change, and community mobilisation, followed the recognition that targeted case finding and contact tracing could not be scaled to meet the exponentially growing burden during the early phase of the epidemic. However, these latter measures, supported by continued community mobilisation, should be prioritised during new Ebola outbreaks and during the end phase of the current epidemic, when capacity can meet need.</p>
<p>Our analyses provide a quantitative basis for prevention measures against the spread of Ebola, but also highlight the challenges faced in the field. A compassionate response protocol needs to acknowledge that, as we found, most reported potential transmissions occurred between family members close to the time of death of the case. This provides evidence that ring vaccination methods, such as those trialled in Guinea [<xref ref-type="bibr" rid="pmed.1002170.ref045">45</xref>], may be an effective way of delivering vaccines against Ebola in the context of limited supply or in hard-to-reach populations. Hospitalisation was found to be protective, but left substantial room for improvement. The association between reported funeral attendance and district-level epidemic trends highlights the continued need for improving access to and acceptability of safe burials of Ebola cases. More robust associations could be detected using case-control studies, but these are hard to coordinate during an emergency situation. In their absence, the analyses reported here have already provided key insights into the drivers of the epidemic. Heterogeneities in transmission made the road to Ebola elimination likely to be marked by episodic flare-ups [<xref ref-type="bibr" rid="pmed.1002170.ref046">46</xref>,<xref ref-type="bibr" rid="pmed.1002170.ref047">47</xref>]. Ebola is controllable using the simple measures that have already been implemented in this outbreak, but complacency as case numbers decline could prolong the epidemic for months. Continued real-time data capture, reporting, and analysis are vital to track transmission patterns, inform resource deployment, and thus hasten elimination of the virus from the human population.</p>
</sec>
<sec id="sec032">
<title>Supporting Information</title>
<supplementary-material id="pmed.1002170.s001" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.s001" xlink:type="simple">
<label>S1 STROBE Checklist</label>
<caption>
<title/>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pmed.1002170.s002" mimetype="application/vnd.openxmlformats-officedocument.wordprocessingml.document" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.s002" xlink:type="simple">
<label>S1 Text</label>
<caption>
<title>Additional methods and results.</title>
<p>(DOCX)</p>
</caption>
</supplementary-material>
<supplementary-material id="pmed.1002170.s003" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.s003" xlink:type="simple">
<label>S2 Text</label>
<caption>
<title>Long version of the case investigation form used in Sierra Leone and Liberia.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pmed.1002170.s004" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.s004" xlink:type="simple">
<label>S3 Text</label>
<caption>
<title>Long version of the case investigation form used in Guinea.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pmed.1002170.s005" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.s005" xlink:type="simple">
<label>S4 Text</label>
<caption>
<title>Short version of the case investigation form used in Sierra Leone.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pmed.1002170.s006" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.s006" xlink:type="simple">
<label>S5 Text</label>
<caption>
<title>Short version of the case investigation form used in Liberia.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
<supplementary-material id="pmed.1002170.s007" mimetype="application/pdf" position="float" xlink:href="info:doi/10.1371/journal.pmed.1002170.s007" xlink:type="simple">
<label>S6 Text</label>
<caption>
<title>Short version of the case investigation form used in Guinea.</title>
<p>(PDF)</p>
</caption>
</supplementary-material>
</sec>
</body>
<back>
<ack>
<p>The authors would like to thank the many field staff from Guinea, Liberia, and Sierra Leone involved in Ebola case finding, detailed data collection, treatment and testing of patients, and data entry. This study was carried out in support of the Ebola response in Guinea, Liberia, and Sierra Leone, and is based on data routinely collected by national and international staff in collaboration with WHO.</p>
<p>The authors would also like to thank Sir David Cox for his helpful advice.</p>
<p>The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U. S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors’ affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.</p>
</ack>
<glossary>
<title>Abbreviations</title>
<def-list>
<def-item><term>CP</term>
<def><p>confirmed or probable</p></def>
</def-item>
<def-item><term>ETU</term>
<def><p>Ebola treatment unit</p></def>
</def-item>
<def-item><term>HCW</term>
<def><p>health care worker</p></def>
</def-item>
<def-item><term>OR</term>
<def><p>odds ratio</p></def>
</def-item>
</def-list>
</glossary>
<ref-list>
<title>References</title>
<ref id="pmed.1002170.ref001"><label>1</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gire</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Goba</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Andersen</surname> <given-names>KG</given-names></name>, <name name-style="western"><surname>Sealfon</surname> <given-names>RS</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Kanneh</surname> <given-names>L</given-names></name>, <etal>et al</etal>. <article-title>Genomic surveillance elucidates Ebola virus origin and transmission during the 2014 outbreak</article-title>. <source>Science</source>. <year>2014</year>;<volume>345</volume>(<issue>6202</issue>):<fpage>1369</fpage>–<lpage>72</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1126/science.1259657" xlink:type="simple">10.1126/science.1259657</ext-link></comment> <object-id pub-id-type="pmid">25214632</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref002"><label>2</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Baize</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Pannetier</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Oestereich</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Rieger</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Koivogui</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Magassouba</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Emergence of Zaire Ebola virus disease in Guinea</article-title>. <source>N Engl J Med</source>. <year>2014</year>;<volume>371</volume>(<issue>15</issue>):<fpage>1418</fpage>–<lpage>25</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1404505" xlink:type="simple">10.1056/NEJMoa1404505</ext-link></comment> <object-id pub-id-type="pmid">24738640</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref003"><label>3</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Borchert</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mutyaba</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>Van Kerkhove</surname> <given-names>MD</given-names></name>, <name name-style="western"><surname>Lutwama</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Luwaga</surname> <given-names>H</given-names></name>, <name name-style="western"><surname>Bisoborwa</surname> <given-names>G</given-names></name>, <etal>et al</etal>. <article-title>Ebola haemorrhagic fever outbreak in Masindi District, Uganda: outbreak description and lessons learned</article-title>. <source>BMC Infect Dis</source>. <year>2011</year>;<volume>11</volume>:<fpage>357</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1186/1471-2334-11-357" xlink:type="simple">10.1186/1471-2334-11-357</ext-link></comment> <object-id pub-id-type="pmid">22204600</object-id>; PubMed Central PMCID: PMC3276451.</mixed-citation></ref>
<ref id="pmed.1002170.ref004"><label>4</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Breman</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Piot</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Johnson</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>White</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Mbuyi</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sureau</surname> <given-names>P</given-names></name>, <etal>et al</etal>. <chapter-title>The epidemiology of Ebola hemorrhagic fever in Zaire, 1976</chapter-title>. In: <name name-style="western"><surname>Pattyn</surname> <given-names>SR</given-names></name>, editor. <source>Ebola virus haemorrhagic fever</source>. <publisher-loc>Amsterdam</publisher-loc>: <publisher-name>Elsevier</publisher-name>; <year>1978</year>. pp. <fpage>103</fpage>–<lpage>24</lpage>.</mixed-citation></ref>
<ref id="pmed.1002170.ref005"><label>5</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Commission</surname> <given-names>International</given-names></name>. <article-title>Ebola haemorrhagic fever in Zaire, 1976</article-title>. <source>Bull World Health Organ</source>. <year>1978</year>;<volume>56</volume>(<issue>2</issue>):<fpage>271</fpage>–<lpage>93</lpage>. <object-id pub-id-type="pmid">307456</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref006"><label>6</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>Ebola haemorrhagic fever in Sudan, 1976</collab>. <article-title>Report of a WHO/International Study Team</article-title>. <source>Bull World Health Organ</source>. <year>1978</year>;<volume>56</volume>(<fpage>2247</fpage>–<lpage>70</lpage>).</mixed-citation></ref>
<ref id="pmed.1002170.ref007"><label>7</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Alexander</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Sanderson</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Marathe</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Lewis</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Rivers</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Shaman</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>What factors might have led to the emergence of Ebola in West Africa</article-title>. <source>PLoS Negl Trop Dis</source>. <year>2015</year>;<volume>9</volume>(<issue>6</issue>):<fpage>e0003652</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pntd.0003652" xlink:type="simple">10.1371/journal.pntd.0003652</ext-link></comment> <object-id pub-id-type="pmid">26042592</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref008"><label>8</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Chan</surname> <given-names>M</given-names></name>. <article-title>Ebola virus disease in West Africa—no early end to the outbreak</article-title>. <source>N Engl J Med</source>. <year>2014</year>;<volume>371</volume>(<issue>13</issue>):<fpage>1183</fpage>–<lpage>5</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMp1409859" xlink:type="simple">10.1056/NEJMp1409859</ext-link></comment> <object-id pub-id-type="pmid">25140856</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref009"><label>9</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization</collab>. <chapter-title>Ebola response roadmap situation report</chapter-title>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2014</year> <month>Nov</month> <day>12</day> [cited 2016 Oct 12]. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/iris/bitstream/10665/141468/1/roadmapsitrep_12Nov2014_eng.pdf" xlink:type="simple">http://apps.who.int/iris/bitstream/10665/141468/1/roadmapsitrep_12Nov2014_eng.pdf</ext-link>.</mixed-citation></ref>
<ref id="pmed.1002170.ref010"><label>10</label><mixed-citation publication-type="book" xlink:type="simple"><publisher-name>World Health Organization</publisher-name>. <chapter-title>Ebola situation report—17 June 2015</chapter-title>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2015</year> <month>Jun</month> <day>17</day> [cited 2016 Oct 12]. Available from: <ext-link ext-link-type="uri" xlink:href="http://apps.who.int/ebola/current-situation/ebola-situation-report-17-june-2015" xlink:type="simple">http://apps.who.int/ebola/current-situation/ebola-situation-report-17-june-2015</ext-link>.</mixed-citation></ref>
<ref id="pmed.1002170.ref011"><label>11</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>WHO Ebola Response Team</collab>. <article-title>Ebola virus disease in West Africa—the first 9 months of the epidemic and forward projections</article-title>. <source>N Engl J Med</source>. <year>2014</year>;<volume>371</volume>(<issue>16</issue>):<fpage>1481</fpage>–<lpage>95</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMoa1411100" xlink:type="simple">10.1056/NEJMoa1411100</ext-link></comment> <object-id pub-id-type="pmid">25244186</object-id>; PubMed Central PMCID: PMC4235004.</mixed-citation></ref>
<ref id="pmed.1002170.ref012"><label>12</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>WHO Ebola Response Team</collab>. <article-title>West African Ebola epidemic after one year—slowing but not yet under control</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>372</volume>(<issue>6</issue>):<fpage>584</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMc1414992" xlink:type="simple">10.1056/NEJMc1414992</ext-link></comment> <object-id pub-id-type="pmid">25539446</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref013"><label>13</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>WHO Ebola Response Team</collab>. <article-title>Ebola virus disease among children in West Africa</article-title>. <source>N Engl J Med</source>. <year>2015</year>;<volume>372</volume>(<issue>13</issue>):<fpage>1274</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1056/NEJMc1415318" xlink:type="simple">10.1056/NEJMc1415318</ext-link></comment> <object-id pub-id-type="pmid">25806936</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref014"><label>14</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>WHO Ebola Response Team</collab>. <article-title>Ebola virus disease among male and female persons in West Africa</article-title>. <source>N Engl J Med</source>. <year>2016</year>;<volume>2016</volume>(<issue>374</issue>):<fpage>96</fpage>–<lpage>8</lpage>.</mixed-citation></ref>
<ref id="pmed.1002170.ref015"><label>15</label><mixed-citation publication-type="other" xlink:type="simple">National Institute of Standards and Technology. Secure Hash Standard (SHS). FIPS 180–4. Gaithersburg (Maryland): National Institute of Standards and Technology; 2015 Aug [cited 2016 Oct 20]. Available from: <ext-link ext-link-type="uri" xlink:href="http://csrc.nist.gov/publications/fips/fips180-4/fips-180-4.pdf" xlink:type="simple">http://csrc.nist.gov/publications/fips/fips180-4/fips-180-4.pdf</ext-link>.</mixed-citation></ref>
<ref id="pmed.1002170.ref016"><label>16</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization</collab>. <chapter-title>Case definition recommendations for Ebola or Marburg virus diseases</chapter-title>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2014</year> <month>Aug</month> <day>9</day> [cited 2016 Oct 12]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/resources/publications/ebola/ebola-case-definition-contact-en.pdf" xlink:type="simple">http://www.who.int/csr/resources/publications/ebola/ebola-case-definition-contact-en.pdf</ext-link>.</mixed-citation></ref>
<ref id="pmed.1002170.ref017"><label>17</label><mixed-citation publication-type="book" xlink:type="simple"><name name-style="western"><surname>Burnham</surname> <given-names>KP</given-names></name>, <name name-style="western"><surname>Anderson</surname> <given-names>DR</given-names></name>. <chapter-title>Model selection and multimodel inference: a practical information-theoretic approach</chapter-title>. <edition>2nd ed.</edition> <publisher-loc>New York</publisher-loc>: <publisher-name>Springer-Verlag</publisher-name>; <year>2002</year>.</mixed-citation></ref>
<ref id="pmed.1002170.ref018"><label>18</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fraser</surname> <given-names>C</given-names></name>. <article-title>Estimating individual and household reproduction numbers in an emerging epidemic</article-title>. <source>PLoS ONE</source>. <year>2007</year>;<volume>2</volume>(<issue>8</issue>):<fpage>e758</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pone.0000758" xlink:type="simple">10.1371/journal.pone.0000758</ext-link></comment> <object-id pub-id-type="pmid">17712406</object-id>; PubMed Central PMCID: PMC1950082.</mixed-citation></ref>
<ref id="pmed.1002170.ref019"><label>19</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cori</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Ferguson</surname> <given-names>NM</given-names></name>, <name name-style="western"><surname>Fraser</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Cauchemez</surname> <given-names>S</given-names></name>. <article-title>A new framework and software to estimate time-varying reproduction numbers during epidemics</article-title>. <source>Am J Epidemiol</source>. <year>2013</year>;<volume>178</volume>(<issue>9</issue>):<fpage>1505</fpage>–<lpage>12</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/aje/kwt133" xlink:type="simple">10.1093/aje/kwt133</ext-link></comment> <object-id pub-id-type="pmid">24043437</object-id>; PubMed Central PMCID: PMC3816335.</mixed-citation></ref>
<ref id="pmed.1002170.ref020"><label>20</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Ripley</surname> <given-names>BD</given-names></name>, <name name-style="western"><surname>Thompson</surname> <given-names>M</given-names></name>. <article-title>Regression techniques for the detection of analytical bias</article-title>. <source>Analyst</source>. <year>1987</year>;<volume>112</volume>:<fpage>377</fpage>–<lpage>83</lpage>.</mixed-citation></ref>
<ref id="pmed.1002170.ref021"><label>21</label><mixed-citation publication-type="other" xlink:type="simple">Therneau T. deming: Deming, Thiel-Sen and Passing-Bablock Regression. Version 1.0–1. R Project for Statistical Computing; 2014 Sep 24 [cited 2016 Oct 12]. Available from: <ext-link ext-link-type="uri" xlink:href="http://CRAN.R-project.org/package=deming" xlink:type="simple">http://CRAN.R-project.org/package=deming</ext-link>.</mixed-citation></ref>
<ref id="pmed.1002170.ref022"><label>22</label><mixed-citation publication-type="other" xlink:type="simple">R Foundation. The R Project for Statistical Computing. Vienna: R Foundation; 2014 [cited 2016 Oct 20]. Available from: <ext-link ext-link-type="uri" xlink:href="https://www.r-project.org/" xlink:type="simple">https://www.r-project.org/</ext-link>.</mixed-citation></ref>
<ref id="pmed.1002170.ref023"><label>23</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dowell</surname> <given-names>SF</given-names></name>, <name name-style="western"><surname>Mukunu</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Ksiazek</surname> <given-names>TG</given-names></name>, <name name-style="western"><surname>Khan</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Rollin</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Peters</surname> <given-names>CJ</given-names></name>. <article-title>Transmission of Ebola hemorrhagic fever: a study of risk factors in family members, Kikwit, Democratic Republic of the Congo, 1995. Commission de Lutte contre les Epidemies a Kikwit</article-title>. <source>J Infect Dis</source>. <year>1999</year>;<volume>179</volume>(<issue>Suppl 1</issue>):<fpage>S87</fpage>–<lpage>91</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/514284" xlink:type="simple">10.1086/514284</ext-link></comment> <object-id pub-id-type="pmid">9988169</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref024"><label>24</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Wamala</surname> <given-names>JF</given-names></name>, <name name-style="western"><surname>Lukwago</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Malimbo</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Nguku</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Yoti</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Musenero</surname> <given-names>M</given-names></name>, <etal>et al</etal>. <article-title>Ebola hemorrhagic fever associated with novel virus strain, Uganda, 2007–2008</article-title>. <source>Emerg Infect Dis</source>. <year>2010</year>;<volume>16</volume>(<issue>7</issue>):<fpage>1087</fpage>–<lpage>92</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid1607.091525" xlink:type="simple">10.3201/eid1607.091525</ext-link></comment> <object-id pub-id-type="pmid">20587179</object-id>; PubMed Central PMCID: PMC3321896.</mixed-citation></ref>
<ref id="pmed.1002170.ref025"><label>25</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Francesconi</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Yoti</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Declich</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Onek</surname> <given-names>PA</given-names></name>, <name name-style="western"><surname>Fabiani</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Olango</surname> <given-names>J</given-names></name>, <etal>et al</etal>. <article-title>Ebola hemorrhagic fever transmission and risk factors of contacts, Uganda</article-title>. <source>Emerg Infect Dis</source>. <year>2003</year>;<volume>9</volume>(<issue>11</issue>):<fpage>1430</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid0911.030339" xlink:type="simple">10.3201/eid0911.030339</ext-link></comment> <object-id pub-id-type="pmid">14718087</object-id>; PubMed Central PMCID: PMC3035551.</mixed-citation></ref>
<ref id="pmed.1002170.ref026"><label>26</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lloyd-Smith</surname> <given-names>JO</given-names></name>, <name name-style="western"><surname>Schreiber</surname> <given-names>SJ</given-names></name>, <name name-style="western"><surname>Kopp</surname> <given-names>PE</given-names></name>, <name name-style="western"><surname>Getz</surname> <given-names>WM</given-names></name>. <article-title>Superspreading and the effect of individual variation on disease emergence</article-title>. <source>Nature</source>. <year>2005</year>;<volume>438</volume>(<issue>7066</issue>):<fpage>355</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1038/nature04153" xlink:type="simple">10.1038/nature04153</ext-link></comment> <object-id pub-id-type="pmid">16292310</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref027"><label>27</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Pathmanathan</surname> <given-names>I</given-names></name>, <name name-style="western"><surname>O’Connor</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Adams</surname> <given-names>ML</given-names></name>, <name name-style="western"><surname>Rao</surname> <given-names>CY</given-names></name>, <name name-style="western"><surname>Kilmarx</surname> <given-names>PH</given-names></name>, <name name-style="western"><surname>Park</surname> <given-names>BJ</given-names></name>, <etal>et al</etal>. <article-title>Rapid assessment of Ebola infection prevention and control needs—six districts, Sierra Leone, October 2014</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2014</year>;<volume>63</volume>(<issue>49</issue>):<fpage>1172</fpage>–<lpage>4</lpage>. <object-id pub-id-type="pmid">25503922</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref028"><label>28</label><mixed-citation publication-type="book" xlink:type="simple"><collab>World Health Organization</collab>. <chapter-title>Ebola outbreak 2014–2015</chapter-title>. <publisher-loc>Geneva</publisher-loc>: <publisher-name>World Health Organization</publisher-name>; <year>2016</year> [cited 2016 Oct 12]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.who.int/csr/disease/ebola/en/" xlink:type="simple">http://www.who.int/csr/disease/ebola/en/</ext-link>.</mixed-citation></ref>
<ref id="pmed.1002170.ref029"><label>29</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Faye</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Boelle</surname> <given-names>PY</given-names></name>, <name name-style="western"><surname>Heleze</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Faye</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Loucoubar</surname> <given-names>C</given-names></name>, <name name-style="western"><surname>Magassouba</surname> <given-names>N</given-names></name>, <etal>et al</etal>. <article-title>Chains of transmission and control of Ebola virus disease in Conakry, Guinea, in 2014: an observational study</article-title>. <source>Lancet Infect Dis</source>. <year>2015</year>;<volume>15</volume>(<issue>3</issue>):<fpage>320</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/S1473-3099(14)71075-8" xlink:type="simple">10.1016/S1473-3099(14)71075-8</ext-link></comment> <object-id pub-id-type="pmid">25619149</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref030"><label>30</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nyenswah</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Fallah</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Calvert</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Duwor</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Hamilton</surname> <given-names>E</given-names></name>, <name name-style="western"><surname>Mokashi</surname> <given-names>V</given-names></name>, <etal>et al</etal>. <article-title>Cluster of Ebola virus disease, Bong and Montserrado Counties, Liberia</article-title>. <source>Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>(<issue>7</issue>):<fpage>1253</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2107.150511" xlink:type="simple">10.3201/eid2107.150511</ext-link></comment> <object-id pub-id-type="pmid">26079309</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref031"><label>31</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Nyenswah</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Fallah</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Sieh</surname> <given-names>S</given-names></name>, <name name-style="western"><surname>Kollie</surname> <given-names>K</given-names></name>, <name name-style="western"><surname>Badio</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Gray</surname> <given-names>A</given-names></name>, <etal>et al</etal>. <article-title>Controlling the last known cluster of Ebola virus disease—Liberia, January–February 2015</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2015</year>:<volume>64</volume>:<fpage>500</fpage>–<lpage>4</lpage>. <object-id pub-id-type="pmid">25974635</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref032"><label>32</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Dietz</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Jambai</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Paweska</surname> <given-names>JT</given-names></name>, <name name-style="western"><surname>Yoti</surname> <given-names>Z</given-names></name>, <name name-style="western"><surname>Ksaizek</surname> <given-names>TG</given-names></name>. <article-title>Epidemiology and risk factors for Ebola virus infection in Sierra Leone—May 23, 2014–January 31, 2015</article-title>. <source>Clin Infect Dis</source>. <year>2015</year>;<volume>61</volume>(<issue>11</issue>):<fpage>1648</fpage>–<lpage>54</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/cid/civ568" xlink:type="simple">10.1093/cid/civ568</ext-link></comment> <object-id pub-id-type="pmid">26179011</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref033"><label>33</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Lindblade</surname> <given-names>KA</given-names></name>, <name name-style="western"><surname>Kateh</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Nagbe</surname> <given-names>TK</given-names></name>, <name name-style="western"><surname>Neatherlin</surname> <given-names>JC</given-names></name>, <name name-style="western"><surname>Pillai</surname> <given-names>SK</given-names></name>, <name name-style="western"><surname>Attfield</surname> <given-names>KR</given-names></name>, <etal>et al</etal>. <article-title>Decreased Ebola transmission after rapid response to outbreaks in remote areas, Liberia, 2014</article-title>. <source>Emerg Infect Dis</source>. <year>2015</year>;<volume>21</volume>(<issue>10</issue>):<fpage>1800</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.3201/eid2110.150912" xlink:type="simple">10.3201/eid2110.150912</ext-link></comment> <object-id pub-id-type="pmid">26402477</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref034"><label>34</label><mixed-citation publication-type="other" xlink:type="simple">Lamunu M, Lutwama JJ, Kamugisha J, Opio A, Nambooze J, Ndayimirije N, et al. Containing hemorrhagic fever epidemic, the ebola experience in Uganda (October 2000–January 2001). 10th International Congress on Infectious Diseases; 2002 Mar 11–14; Singapore.</mixed-citation></ref>
<ref id="pmed.1002170.ref035"><label>35</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Roels</surname> <given-names>TH</given-names></name>, <name name-style="western"><surname>Bloom</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Buffington</surname> <given-names>J</given-names></name>, <name name-style="western"><surname>Muhungu</surname> <given-names>GL</given-names></name>, <name name-style="western"><surname>Mac Kenzie</surname> <given-names>WR</given-names></name>, <name name-style="western"><surname>Khan</surname> <given-names>AS</given-names></name>, <etal>et al</etal>. <article-title>Ebola hemorrhagic fever, Kikwit, Democratic Republic of the Congo, 1995: risk factors for patients without a reported exposure</article-title>. <source>J Infect Dis</source>. <year>1999</year>;<volume>179</volume>(<issue>Suppl 1</issue>):<fpage>S92</fpage>–<lpage>7</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1086/514286" xlink:type="simple">10.1086/514286</ext-link></comment> <object-id pub-id-type="pmid">9988170</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref036"><label>36</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fitzpatrick</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Vogt</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Gbabai</surname> <given-names>OBM</given-names></name>, <name name-style="western"><surname>Decroo</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Keane</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>De Clerck</surname> <given-names>H</given-names></name>, <etal>et al</etal>. <article-title>The contribution of Ebola viral load at admission and other patient characteristics to mortality in a Médecins Sans Frontières (MSF) Ebola Case Management Centre (CMC), Kailahun, Sierra Leone, June–October, 2014</article-title>. <source>J Infect Dis</source>. <year>2015</year>;<volume>212</volume>(<issue>11</issue>):<fpage>1752</fpage>–<lpage>8</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/infdis/jiv304" xlink:type="simple">10.1093/infdis/jiv304</ext-link></comment> <object-id pub-id-type="pmid">26002981</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref037"><label>37</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Fasina</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Shittu</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Lazarus</surname> <given-names>D</given-names></name>, <name name-style="western"><surname>Tomori</surname> <given-names>O</given-names></name>, <name name-style="western"><surname>Simonsen</surname> <given-names>L</given-names></name>, <name name-style="western"><surname>Viboud</surname> <given-names>C</given-names></name>, <etal>et al</etal>. <article-title>Transmission dynamics and control of Ebola virus disease outbreak in Nigeria, July to September 2014</article-title>. <source>Euro Surveill</source>. <year>2014</year>;<volume>19</volume>(<issue>40</issue>):<fpage>20920</fpage>. <object-id pub-id-type="pmid">25323076</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref038"><label>38</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Khan</surname> <given-names>AS</given-names></name>, <name name-style="western"><surname>Tshioko</surname> <given-names>FK</given-names></name>, <name name-style="western"><surname>Heymann</surname> <given-names>DL</given-names></name>, <name name-style="western"><surname>Le Guenno</surname> <given-names>B</given-names></name>, <name name-style="western"><surname>Nabeth</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Kerstiëns</surname> <given-names>B</given-names></name>, <etal>et al</etal>. <article-title>The reemergence of Ebola hemorrhagic fever, Democratic Republic of the Congo, 1995</article-title>. <source>J Infect Dis</source>. <year>1999</year>;<volume>179</volume>(<issue>Suppl 1</issue>):<fpage>S76</fpage>–<lpage>86</lpage>.</mixed-citation></ref>
<ref id="pmed.1002170.ref039"><label>39</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Cori</surname> <given-names>A</given-names></name>, <name name-style="western"><surname>Boelle</surname> <given-names>PY</given-names></name>, <name name-style="western"><surname>Thomas</surname> <given-names>G</given-names></name>, <name name-style="western"><surname>Leung</surname> <given-names>GM</given-names></name>, <name name-style="western"><surname>Valleron</surname> <given-names>AJ</given-names></name>. <article-title>Temporal variability and social heterogeneity in disease transmission: the case of SARS in Hong Kong</article-title>. <source>PLoS Comput Biol</source>. <year>2009</year>;<volume>5</volume>(<issue>8</issue>):<fpage>e1000471</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.1000471" xlink:type="simple">10.1371/journal.pcbi.1000471</ext-link></comment> <object-id pub-id-type="pmid">19696879</object-id>; PubMed Central PMCID: PMC2717369.</mixed-citation></ref>
<ref id="pmed.1002170.ref040"><label>40</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Li</surname> <given-names>Y</given-names></name>, <name name-style="western"><surname>Yu</surname> <given-names>IT</given-names></name>, <name name-style="western"><surname>Xu</surname> <given-names>P</given-names></name>, <name name-style="western"><surname>Lee</surname> <given-names>JH</given-names></name>, <name name-style="western"><surname>Wong</surname> <given-names>TW</given-names></name>, <name name-style="western"><surname>Ooi</surname> <given-names>PL</given-names></name>, <etal>et al</etal>. <article-title>Predicting super spreading events during the 2003 severe acute respiratory syndrome epidemics in Hong Kong and Singapore</article-title>. <source>Am J Epidemiol</source>. <year>2004</year>;<volume>160</volume>(<issue>8</issue>):<fpage>719</fpage>–<lpage>28</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1093/aje/kwh273" xlink:type="simple">10.1093/aje/kwh273</ext-link></comment> <object-id pub-id-type="pmid">15466494</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref041"><label>41</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Stein</surname> <given-names>RA</given-names></name>. <article-title>Super-spreaders in infectious diseases</article-title>. <source>Int J Infect Dis</source>. <year>2011</year>;<volume>15</volume>(<issue>8</issue>):<fpage>e510</fpage>–<lpage>3</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1016/j.ijid.2010.06.020" xlink:type="simple">10.1016/j.ijid.2010.06.020</ext-link></comment> <object-id pub-id-type="pmid">21737332</object-id>.</mixed-citation></ref>
<ref id="pmed.1002170.ref042"><label>42</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gostin</surname> <given-names>LO</given-names></name>, <name name-style="western"><surname>Lucey</surname> <given-names>D</given-names></name>. <article-title>Middle East respiratory syndrome: a global health challenge</article-title>. <source>JAMA</source>. <year>2015</year>;<volume>314</volume>(<issue>8</issue>):<fpage>771</fpage>–<lpage>2</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1001/jama.2015.7646" xlink:type="simple">10.1001/jama.2015.7646</ext-link></comment> <object-id pub-id-type="pmid">26084030</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref043"><label>43</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Watts</surname> <given-names>DJ</given-names></name>, <name name-style="western"><surname>Muhamad</surname> <given-names>R</given-names></name>, <name name-style="western"><surname>Medina</surname> <given-names>DC</given-names></name>, <name name-style="western"><surname>Dodds</surname> <given-names>PS</given-names></name>. <article-title>Multiscale, resurgent epidemics in a hierarchical metapopulation model</article-title>. <source>Proc Natl Acad Sci U S A</source>. <year>2005</year>;<volume>102</volume>(<issue>32</issue>):<fpage>11157</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1073/pnas.0501226102" xlink:type="simple">10.1073/pnas.0501226102</ext-link></comment> <object-id pub-id-type="pmid">16055564</object-id>; PubMed Central PMCID: PMC1183543.</mixed-citation></ref>
<ref id="pmed.1002170.ref044"><label>44</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Salathe</surname> <given-names>M</given-names></name>, <name name-style="western"><surname>Jones</surname> <given-names>JH</given-names></name>. <article-title>Dynamics and control of diseases in networks with community structure</article-title>. <source>PLoS Comput Biol</source>. <year>2010</year>;<volume>6</volume>(<issue>4</issue>):<fpage>e1000736</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1371/journal.pcbi.1000736" xlink:type="simple">10.1371/journal.pcbi.1000736</ext-link></comment> <object-id pub-id-type="pmid">20386735</object-id>; PubMed Central PMCID: PMC2851561.</mixed-citation></ref>
<ref id="pmed.1002170.ref045"><label>45</label><mixed-citation publication-type="journal" xlink:type="simple"><collab>Ebola ça Suffit Ring Vaccination Trial Consortium</collab>. <article-title>The ring vaccination trial: a novel cluster randomized controlled trial design to evaluate vaccine efficacy and effectiveness during outbreaks, with special reference to Ebola</article-title>. <source>BMJ</source>. <year>2015</year>;<volume>351</volume>:<fpage>h3740</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.h3740" xlink:type="simple">10.1136/bmj.h3740</ext-link></comment> <object-id pub-id-type="pmid">26215666</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref046"><label>46</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Victory</surname> <given-names>KR</given-names></name>, <name name-style="western"><surname>Coronado</surname> <given-names>F</given-names></name>, <name name-style="western"><surname>Ifono</surname> <given-names>SO</given-names></name>, <name name-style="western"><surname>Soropogui</surname> <given-names>T</given-names></name>, <name name-style="western"><surname>Dahl</surname> <given-names>BA</given-names></name>. <article-title>Ebola transmission linked to a single traditional funeral ceremony—Kissidougou, Guinea, December, 2014–January 2015</article-title>. <source>MMWR Morb Mortal Wkly Rep</source>. <year>2015</year>;<volume>64</volume>(<issue>14</issue>):<fpage>386</fpage>–<lpage>8</lpage>. <object-id pub-id-type="pmid">25879897</object-id></mixed-citation></ref>
<ref id="pmed.1002170.ref047"><label>47</label><mixed-citation publication-type="journal" xlink:type="simple"><name name-style="western"><surname>Gulland</surname> <given-names>A</given-names></name>. <article-title>Liberia confirms Ebola case two months after being declared free of the disease</article-title>. <source>BMJ</source>. <year>2015</year>;<volume>350</volume>:<fpage>h3620</fpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="http://dx.doi.org/10.1136/bmj.h3620" xlink:type="simple">10.1136/bmj.h3620</ext-link></comment> <object-id pub-id-type="pmid">26138714</object-id></mixed-citation></ref>
</ref-list>
</back>
</article>